PATH: Form 990, tax year 2012
View the entire original 990 at ProPublica ↗
- Organization
- PATH (EIN 91-1157127)
- Tax period
- 2012-01-01 to 2012-12-31
- Filed
- 2013-11-13
- IRS object ID
- 201323179349302292
- Schema version
- 2012v2.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2013-11-13T11:02:31-06:00 | Timestamp |
| Tax Period End Date | 2012-12-31 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 521392008 | EIN |
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | GELMAN ROSENBERG & FREEDMAN | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4550 MONTGOMERY AVE SUITE 650N | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 208142930 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2012-01-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 911157127 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PROGRAM FOR APPROPRIATE TECHNOLOGY IN | BusinessNameLine1 |
| Business Name Line2 | HEALTH (PATH) | BusinessNameLine2 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | PROG | NameControl |
| Phone | 2062853500 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2201 WESTLAKE AVENUE NO 200 | AddressLine1 |
| City | SEATTLE | City |
| State | WA | State |
| ZIP Code | 98121 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | OLIVIA POLIUS | Name |
| Title | PRESIDENT & CEO | Title |
| Phone | 2062853500 | Phone |
| Date Signed | 2013-11-13 | DateSigned |
| Authorize Third Party | 1 | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 3019519090 | Phone |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2012 | TaxYear |
| Build TS | 2016-02-25 16:41:14Z | BuildTS |
Form 990 IRS990
Doing Business As DoingBusinessAs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PATH | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | STEVE DAVIS | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2201 WESTLAKE AVENUE NO 200 | AddressLine1 |
| City | SEATTLE | City |
| State | WA | State |
| ZIP Code | 98121 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 250492013 | GrossReceipts |
| Group Return For Affiliates | 0 | GroupReturnForAffiliates |
| Organization501c3 | X | Organization501c3 |
| Web Site | WWW.PATH.ORG | WebSite |
| Type Of Organization Corporation | X | TypeOfOrganizationCorporation |
| Year Formation | 1981 | YearFormation |
| State Legal Domicile | WA | StateLegalDomicile |
| Activity Or Mission Description | SEE PART III, LINE 1. | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 11 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 11 | NbrIndependentVotingMembers |
| Total Nbr Employees | 646 | TotalNbrEmployees |
| Total Nbr Volunteers | 0 | TotalNbrVolunteers |
| Total Gross UBI | 0 | TotalGrossUBI |
| Net Unrelated Business Txbl Income | 0 | NetUnrelatedBusinessTxblIncome |
| Contributions Grants Prior Year | 240628741 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 171536869 | ContributionsGrantsCurrentYear |
| Program Service Revenue Prior Year | 79515 | ProgramServiceRevenuePriorYear |
| Program Service Revenue CY | 27292 | ProgramServiceRevenueCY |
| Investment Income Prior Year | 3343515 | InvestmentIncomePriorYear |
| Investment Income Current Year | 2677407 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | 385259 | OtherRevenuePriorYear |
| Other Revenue Current Year | 739627 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | 244437030 | TotalRevenuePriorYear |
| Total Revenue Current Year | 174981195 | TotalRevenueCurrentYear |
| Grants And Similar Amnts Prior Year | 74959310 | GrantsAndSimilarAmntsPriorYear |
| Grants And Similar Amnts CY | 70398415 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members Prior Year | 0 | BenefitsPaidToMembersPriorYear |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 82582493 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 90685304 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp Prior Year | 0 | TotalProfFundrsngExpPriorYear |
| Total Prof Fundrsng Exp CY | 0 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 1528457 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 99424526 | OtherExpensePriorYear |
| Other Expenses Current Year | 113262887 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 256966329 | TotalExpensesPriorYear |
| Total Expenses Current Year | 274346606 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | -12529299 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | -99365411 | RevenuesLessExpensesCY |
| Total Assets BOY | 612675555 | TotalAssetsBOY |
| Total Assets EOY | 507730565 | TotalAssetsEOY |
| Total Liabilities BOY | 66607920 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 59191414 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | 546067635 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | 448539151 | NetAssetsOrFundBalancesEOY |
| Info In Schedule O Part III | X | InfoInScheduleOPartIII |
| Mission Description | PATH IS AN INTERNATIONAL NONPROFIT ORGANIZATION THAT DRIVES TRANSFORMATIVE INNOVATION IN GLOBAL HEALTH. OUR MISSION IS TO IMPROVE THE HEALTH OF PEOPLE AROUND THE WORLD BY ADVANCING SUSTAINABLE TECHNOLOGIES, STRENGTHENING SYSTEMS, AND ENCOURAGING HEALTHY BEHAVIORS. | MissionDescription |
| Significant New Program Services | 0 | SignificantNewProgramServices |
| Significant Change | 0 | SignificantChange |
| Expense | 93084229 | Expense |
| Grants | 27964496 | Grants |
| Revenue | 502 | Revenue |
| Description | EMERGING AND EPIDEMIC DISEASES: EMERGING AND EPIDEMIC DISEASES, INCLUDING MALARIA, HIV/ AIDS, AND TUBERCULOSIS (TB), CLAIM LIVES AND UNDERMINE COMMUNITIES WORLDWIDE. DEVELOPING COUNTRIES, WHERE CHRONIC POVERTY AND WEAK HEALTH SYSTEMS CHALLENGE RESPONSES AND COMPOUND THE BURDEN OF ILLNESS, ARE PARTICULARLY HARD HIT. PATH WORKS WITH PUBLIC- AND PRIVATE-SECTOR PARTNERS, HEALTH ORGANIZATIONS, AND COMMUNITIES TO BREAK THIS CYCLE BY INCREASING PREVENTION, CONTROL, DIAGNOSIS, AND TREATMENT; STRENGTHENING HEALTH SYSTEMS; ADVANCING RELEVANT TECHNOLOGIES AND STRATEGIES; AND EMPOWERING CITIZENS TO ADOPT HEALTHY BEHAVIORS AND CONFRONT HARMFUL SOCIAL NORMS. IN 2012, ONE OF OUR KEY ACHIEVEMENTS WAS THE DEVELOPMENT OF A SEMISYNTHETIC FORM OF ARTEMISININ, THE KEY INGREDIENT IN TOP MALARIA TREATMENTS. OUR DRUG DEVELOPMENT PROGRAM, PATH DRUG SOLUTIONS, WORKED WITH PARTNERS TO DEVELOP AND MANUFACTURE THE DRUG, WHICH WILL SUPPLEMENT FLUCTUATING BOTANICAL SUPPLIES, STABILIZE THE MARKET, AND INCREASE THE AVAILABILITY OF LIFESAVING ANTIMALARIAL MEDICINES. AFTER SUCCESSFULLY COMPLETING PROCESS VALIDATION, WE PRODUCED SEVERAL TONS OF MATERIALS FOR TESTING BY POTENTIAL CUSTOMERS. PRODUCTION IS SET TO GROW IN 2013, AND WILL INCREASE FURTHER BY 2014.TO DECREASE MALARIA TRANSMISSION, PATH WORKS WITH NATIONAL PROGRAMS TO EXPAND COMPREHENSIVE TESTING AND TREATMENT, IMPROVE DATA COLLECTION, AND INCREASE SURVEILLANCE. THESE ACTIVITIES ARE PART OF A STRATEGY TO END TRANSMISSION ALTOGETHER, WITH THE ULTIMATE GOAL OF ELIMINATING MALARIA.FOR EXAMPLE, OUR MALARIACARE PROJECT BEGAN A WIDE-REACHING EFFORT TO IMPROVE DIAGNOSTIC TESTING, TREATMENT, AND LABORATORY SERVICES THROUGHOUT AFRICA, WITH THE GOAL OF CUTTING THE BURDEN OF MALARIA BY HALF AMONG A POPULATION OF 450 MILLION. IN ZAMBIA, WE HELPED TRAIN MORE THAN 1,100 WORKERS TO IDENTIFY, REPORT, TREAT, AND MONITOR INFECTIONS. IN ETHIOPIA, WE PARTNERED WITH LEADERS TO CREATE MALARIA ELIMINATION LEARNING DISTRICTS. AND IN SENEGAL, A NEW EFFORT IS HARNESSING THE POWER OF SMARTPHONES TO REPORT DATA DURING COMMUNITY-WIDE TEST-AND-TREAT CAMPAIGNS. WE ALSO SUPPORTED MALARIA ELIMINATION BY IDENTIFYING AND ANALYZING THE UNIQUE TECHNICAL REQUIREMENTS AND MARKET NEEDS OF DIAGNOSTIC TECHNOLOGIES THAT CAN DETECT REMAINING RESERVOIRS OF INFECTION AMONG PEOPLE WHO MAY NOT SHOW SYMPTOMS. THIS WORK WILL PROVIDE COUNTRIES, DONORS, AND DEVELOPERS WITH EVIDENCE ABOUT COST-EFFECTIVE DIAGNOSTIC TOOLS AND TACTICS AS THEY FOCUS ON ELIMINATION STRATEGIES.TO REDUCE THE BURDEN OF HIV, PATH FOCUSED ON STRENGTHENING DIAGNOSIS, CARE, AND TREATMENT SERVICES; STEPPING UP PREVENTION EFFORTS, INCLUDING PREVENTING MOTHER-TO-CHILD TRANSMISSION; AND BUILDING THE FOUNDATIONS LOCAL AND NATIONAL HEALTH SYSTEMS NEED TO COMBAT THE DISEASE. OUR 2012 EFFORTS INCLUDED PROVIC, A PROJECT IN THE DEMOCRATIC REPUBLIC OF CONGO THAT DREW ON THE RESOURCES OF NEARLY 100 LOCAL PARTNERS TO REACH AN ESTIMATED 1.4 MILLION PEOPLE WITH HIV PREVENTION MESSAGES, 430,000 PEOPLE WITH COUNSELING AND TESTING, AND 80,000 WOMEN WITH SERVICES TO PREVENT MOTHER-TO-CHILD TRANSMISSION OF HIV. PATH ALSO LAUNCHED A PUBLIC-PRIVATE PARTNERSHIP WITH TENKE FUNGURUME MINING, THE COUNTRY'S LARGEST FOREIGN INVESTOR, ALONG THE MINING AND TRUCKING CORRIDORS OF THE SOUTHERN PART OF THE COUNTRY. IN THESE HIV "HOTSPOTS," WE WORKED WITH PARTNERS AT THE COMMUNITY AND CLINIC LEVELS TO ADDRESS HIV AMONG HIGH-RISK POPULATIONS AND PREVENT TRANSMISSION FROM MOTHERS TO THEIR CHILDREN.IN WESTERN KENYA, APHIAPLUS, A COMPREHENSIVE PORTFOLIO OF COMMUNITY-BASED PROGRAMS HAS IMPROVED SERVICES, STRENGTHENED COMMUNITIES, AND CONFRONTED THE SOCIAL AND ECONOMIC CAUSES OF POOR HEALTH. THE PROJECT HAS ALLOWED MORE THAN 500,000 PEOPLE TO GET HIV TESTING AND COUNSELING AND MORE THAN 53,000 TO GET TREATMENT; REACHED 6.6 MILLION KENYAN YOUTH WITH HIV PREVENTION INFORMATION; INCREASED THE NUMBER OF BIRTHS ASSISTED BY SKILLED BIRTH ATTENDANTS TO NEARLY 61,000; AND PROVIDED SCHOOL FEES, CARE, AND DAY-TO-DAY NECESSITIES FOR MORE THAN 170,000 ORPHANS AND VULNERABLE CHILDREN.PATH ALSO WORKS WITH DIVERSE PARTNERS TO COMBAT TB, INCLUDING DRUG-RESISTANT TB, BY IMPROVING DIAGNOSIS, TREATMENT, AND CARE AND INTEGRATING TB INTO HEALTH SERVICES FOR HIV, CHILD HEALTH, DIABETES, AND OTHER CONDITIONS. IN TANZANIA AND ZANZIBAR, FOR EXAMPLE, WE SUPPORTED THE MINISTRIES OF HEALTH IN DEVELOPING AND IMPLEMENTING AN INTEGRATED STRATEGY TO PROVIDE SERVICES TO PATIENTS WITH TB AND HIV THAT IS NOW USED IN MORE THAN 1,000 HEALTH FACILITIES. HEALTH STAFF HAVE IDENTIFIED MORE THAN 23,000 PATIENTS WITH TB, WITH 90% TESTED FOR HIV AND INFORMED OF THEIR RESULTS. | Description |
Activity2 Activity2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 85483955 | Expense |
| Grants | 30775114 | Grants |
| Revenue | 3447 | Revenue |
| Description | VACCINES AND IMMUNIZATION:VACCINES OFFER RELIABLE, LOW-COST PROTECTION AGAINST LIFE-THREATENING DISEASE, MAKING THEM ONE OF THE MOST EFFECTIVE HEALTH INTERVENTIONS OF ALL TIME. IN LOW-RESOURCE COUNTRIES, WHERE HEALTH SERVICES ARE OFTEN TOO REMOTE OR EXPENSIVE TO SAVE CHILDREN'S LIVES ONCE THEY ARE SICK, VACCINES MAY BE THEIR BEST CHANCE FOR SURVIVAL.PATH IS WORKING TO IMPROVE ACCESS TO VACCINES IN LOW-RESOURCE COUNTRIES AROUND THE WORLD. OUR PROJECTS INCREASE AVAILABILITY, ACCELERATE RESEARCH AND DEVELOPMENT, AND STRENGTHEN SUPPLY CHAIN SYSTEMS. THROUGH THIS WORK, WE ARE MAKING PROGRESS AGAINST POTENTIALLY DEADLY HEALTH THREATS SUCH AS CERVICAL CANCER, DIARRHEAL DISEASE, JAPANESE ENCEPHALITIS, MALARIA, MENINGITIS, PANDEMIC INFLUENZA, AND PNEUMOCOCCAL DISEASE. IN 2012, WE USED INNOVATIVE APPROACHES TO BRING VACCINES TO MORE COMMUNITIES, ADVANCED NEW VACCINE CANDIDATES, STRENGTHENED VACCINE SUPPLY CHAINS AND SYSTEMS, AND SUCCESSFULLY ADVOCATED TO PROTECT VACCINES FOR MILLIONS OF CHILDREN.FOR EXAMPLE, PATH SUPPORTED 13 ASIAN COUNTRIES TO SAFELY AND EFFECTIVELY ADOPT A VACCINE AGAINST JAPANESE ENCEPHALITIS, THE LEADING CAUSE OF DISABILITY IN ASIA.IN AFRICA, THE LIFESAVING MENAFRIVAC VACCINE, DEVELOPED THROUGH A PARTNERSHIP BETWEEN PATH AND THE WORLD HEALTH ORGANIZATION (WHO) IN COLLABORATION WITH SERUM INSTITUTE OF INDIA LTD., CONTINUED TO SAVE LIVES. THIS YEAR, 48 MILLION PEOPLE WERE VACCINATED, PART OF THE 100 MILLION PEOPLE ACROSS 10 AFRICAN COUNTRIES WHO HAVE RECEIVED THE VACCINATION SINCE ITS INTRODUCTION. THE VACCINE ALSO BECAME THE FIRST IN AFRICA APPROVED FOR TRANSPORT AND STORAGE OUTSIDE THE TRADITIONAL COLD CHAIN, HELPING HEALTH WORKERS REACH PEOPLE IN REMOTE AREAS.TOGETHER WITH PARTNERS, PATH ALSO ADVANCED THE PROMISING RTS, A MALARIA VACCINE CANDIDATE, WHICH WAS SHOWN TO REDUCE MALARIA EPISODES BY ONE-THIRD AMONG AFRICAN INFANTS(ABOUT 270 CASES AVERTED PER 1,000 INFANTS)AND BY ONE-HALF AMONG TODDLERS (ABOUT 750 CASES AVERTED PER 1,000 TODDLERS) OVER THE FIRST YEAR OF FOLLOW-UP.IN CHINA, WE CREATED A PROJECT DEVELOPMENT PARTNERSHIP WITH PUBLIC- AND PRIVATE-SECTOR PARTNERS TO OBTAIN WHO PREQUALIFICATION OF VACCINES FOR GLOBAL PROCUREMENT PROGRAMS.PROJECT OPTIMIZE, A PATH-WHO COLLABORATION, MADE NEW STRIDES TOWARD STRENGTHENING THE SUPPLY CHAINS AND SYSTEMS THAT MANAGE, STORE, AND DELIVER VACCINES TO THOSE WHO NEED THEM. KEY ACHIEVEMENTS INCLUDED A DIGITAL IMMUNIZATION REGISTRY IN VIETNAM TO MONITOR CHILDREN DUE FOR VACCINATIONS THAT REDUCED THE TIME HEALTH WORKERS SPENT RECORDING DATA BY HAND, PROVIDED A WAY TO REMIND MOTHERS OF UPCOMING VACCINATIONS, AND RESULTED IN A MARKED INCREASE IN ON-TIME VACCINATION RATES. IN SOUTH SUDAN, OUR TESTS OF A CLOUD-BASED SYSTEM TO MANAGE VACCINE STOCKS USING A CELL PHONE PROVIDED A NEW WAY TO TRACK REAL-TIME SUPPLY AND DEMAND. THE TEAM EXPLORED THE USE OF BATTERY-FREE VACCINE REFRIGERATORS AND HYBRID SOLAR-ELECTRIC SYSTEMS TO MAINTAIN THE COLD CHAIN IN RURAL AREAS, AND ELECTRIC VEHICLES AND SPECIALLY EQUIPPED TRUCKS TO STREAMLINE DELIVERY. IN ADDITION, RECOGNIZING THAT VACCINE INTRODUCTION IS ACCELERATING WORLDWIDE, WE CREATED AN INTERACTIVE EXHIBIT TO INTRODUCE LEADERS, LAWMAKERS, AND STAKEHOLDERS TO VACCINE SUPPLY AND LOGISTICS SYSTEMS AND SPARK COMMITMENT AND INNOVATION TO SOLVE CHALLENGES.PATH'S ADVOCACY AND COMMUNICATIONS EFFORTS ALSO ACHIEVED GAINS IN 2012. AS THE LEADER OF THE VACCINE IMPLEMENTATION TECHNICAL ASSISTANCE CONSORTIUM (VITAC, FORMERLY AVI TAC), WE ASSISTED THE GLOBAL ALLIANCE FOR VACCINES AND IMMUNIZATION (GAVI) WITH COMMUNICATIONS AND ADVOCACY SUPPORT, CREATED A STRATEGIC FORECASTING TOOL TO PREDICT VACCINE SUPPLY AND DEMAND, AND DEMONSTRATED THE IMPACT OF ROTAVIRUS AND PNEUMOCOCCAL VACCINES. GHANA AND TANZANIA SIMULTANEOUSLY INTRODUCED BOTH VACCINES INTO THEIR NATIONAL IMMUNIZATION PROGRAMS, AND PATH PROVIDED DOCUMENTATION, ADVOCACY, AND GLOBAL MEDIA RELATIONS SUPPORT FOR THIS BOLD EFFORT. IN MALAWI, PATH OUTREACH AND ADVOCACY SUPPORTED THE NATIONWIDE INTRODUCTION OF A ROTAVIRUS VACCINE.IN ADDITION, PATH ADVOCACY HELPED TO SAFEGUARD ACCESS TO CHILDHOOD VACCINES IN A GLOBAL TREATY LIMITING MERCURY IN THE ENVIRONMENT. TOGETHER WITH PARTNERS, WE INFORMED AND INFLUENCED KEY DECISION-MAKERS, WHO AGREED TO EXCLUDE VACCINES CONTAINING THE PRESERVATIVE THIOMERSAL FROM REGULATION. | Description |
Activity3 Activity3
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 23846345 | Expense |
| Grants | 4290981 | Grants |
| Revenue | 17533 | Revenue |
| Description | HEALTH TECHNOLOGIES:PATH DEVELOPS AND INTRODUCES APPROPRIATE, AFFORDABLE TECHNOLOGIES TO ADDRESS URGENT HEALTH CHALLENGES, PARTICULARLY IN LOW-RESOURCE SETTINGS. OUR LOW-COST, EVIDENCE-BASED PRODUCTS, DESIGNED WITH INPUT FROM USERS AND RECIPIENTS, ARE TRANSFORMING HEALTH WORLDWIDE. WE ALSO IMPROVE THE TECHNOLOGY AND INFORMATION SYSTEMS THAT HELP HEALTH WORKERS MONITOR AND PROVIDE HEALTH SERVICES.PATH'S DIAGNOSTICS WORK INCLUDES DEVELOPING OR ADVANCING AFFORDABLE TESTS FOR THE RAPID DETECTION OF MALARIA, MULTIDRUG-RESISTANT TB, NEGLECTED TROPICAL DISEASES, SEXUALLY TRANSMITTED INFECTIONS, AND OTHER HEALTH CONCERNS. IN 2012, THE CAREHPV TEST, WHICH DETECTS THE CAUSE OF CERVICAL CANCER, WENT ON SALE IN CHINA, AND IT WILL SOON BE AVAILABLE IN INDIA AND OTHER COUNTRIES. THE TEST WAS DEVELOPED BY PATH AND QIAGEN, THE TRADEMARK HOLDER, FOR USE IN EVEN BASIC HEALTH CLINICS, AND CAN BE USED ON SAMPLES SELF-COLLECTED BY WOMEN.IN CAMBODIA, INDIA, MEXICO, AND TANZANIA, PATH EVALUATED NEW TECHNOLOGIES TO IDENTIFY PEOPLE LIVING WITH DIABETES. THIS INCLUDED A RAPID DIAGNOSTIC TEST TO SCREEN PREGNANT WOMEN FOR GESTATIONAL DIABETES.IN ADDITION, WE ADVANCED A LOW-COST, POINT-OF-CARE DIAGNOSTIC TEST FOR ONCHOCERCIASIS (RIVER BLINDNESS) TO AID GLOBAL MONITORING AND ELIMINATION EFFORTS, AND IDENTIFIED A MANUFACTURING PARTNER TO CREATE AND DISTRIBUTE THE PRODUCT. PATH ALSO ADVANCED NEW TREATMENT OPTIONS FOR NEGLECTED TROPICAL DISEASES, INCLUDING A NEW ANTIBIOTIC, CALLED THE PAROMOMYCIN INTRAMUSCULAR INJECTION (PMIM), DEVELOPED BY OUR DRUG DEVELOPMENT PROGRAM, PATH DRUG SOLUTIONS, TO TREAT VISCERAL LEISHMANIASIS. THE INJECTION WAS REGISTERED BY THE GOVERNMENT OF NEPAL, AND WE COMPLETED A PHASE 3(B) CLINICAL TRIAL IN BANGLADESH, SUPPORTING EFFORTS TO REGISTER PMIM THERE AND CONTRIBUTING TO A NATIONAL ELIMINATION STRATEGY.IN ADDITION, WE CONTINUED WORK TO DEVELOP AN ELECTRICITY-FREE NON-INSTRUMENTED NUCLEIC ACID AMPLIFICATION DEVICE. DESIGNED TO DETECT DISEASES, SUCH AS ACUTE AND INFANT HIV, THAT ARE OTHERWISE CHALLENGING TO DIAGNOSE IN LOW-RESOURCE SETTINGS, THIS DEVICE WILL SPEED DIAGNOSIS AND TREATMENT.IN 2012, WE ALSO CONTINUED OUR WORK TO IMPROVE FAMILIES ACCESS TO SAFE WATER. FOR EXAMPLE, WE DEVELOPED DESIGN GUIDELINES NOW BEING USED BY THREE CHINESE MANUFACTURERS SELLING LOW-COST HOUSEHOLD WATER FILTERS. WE USED CREATIVE, MARKET-BASED STRATEGIES, INCLUDING MICROFINANCE LOANS AND COMMERCIAL PARTNERSHIPS, TO PROVIDE THOUSANDS OF LOW-INCOME CONSUMERS IN ASIA AND AFRICA WITH ACCESS TO SAFE WATER. OUR CONTINUED FOCUS ON EFFECTIVE, AFFORDABLE FAMILY PLANNING OPTIONS INCLUDED WORK TO DEVELOP ROBUST AND SUSTAINABLE MARKETS FOR THE EFFECTIVE, EASY-TO-USE SILCS DIAPHRAGM AND TO ADVANCE THE WOMAN'S CONDOM. PATH DESIGNED BOTH TECHNOLOGIES TO BE ACCEPTABLE, AFFORDABLE, AND ACCESSIBLE FOR USERS WORLDWIDE.FINALLY, OUR HEALTH MANAGEMENT INFORMATION SYSTEMS GROUP CONTINUED TO RESEARCH, DEVELOP, AND ADAPT INFORMATION AND COMMUNICATION TECHNOLOGY PRODUCTS (E.G., COMPUTER SOFTWARE) TO HELP HEALTH WORKERS AND LEADERS MONITOR AND PROVIDE SERVICES AT THE LOCAL AND NATIONAL LEVEL. FOR EXAMPLE, WE HELPED HEALTH WORKERS FROM KENYA, RWANDA, SENEGAL, AND VIETNAM IDENTIFY A SET OF BUSINESS PROCESSES AND USER REQUIREMENTS COMMON TO THEIR NATIONAL SUPPLY CHAIN SYSTEMS, INFORMATION THAT MAY BE USED TO IMPROVE SUPPLY CHAINS AND LOGISTICS INFORMATION MANAGEMENT. | Description |
Activity Other ActivityOther (3 entries)
| ExpenseExpense | GrantsGrants | DescriptionDescription | RevenueRevenue |
|---|---|---|---|
| 15406708 | 2240211 | MATERNAL AND CHILD HEALTH:PATH IMPROVES THE HEALTH OF WOMEN AND CHILDREN THROUGH EVIDENCE-BASED APPROACHES THAT ADDRESS THE LEADING CAUSES OF MATERNAL AND CHILD DEATH IN LOW-INCOME COUNTRIES. IN 2012, OUR PROJECTS FOCUSED ON INNOVATIVE INTERVENTIONS AND TECHNOLOGIES TO IMPROVE SAFE BIRTH AND NEWBORN CARE, BOLSTER NUTRITION, CONTROL AND PREVENT PNEUMONIA AND DIARRHEAL DISEASE, AND ADVANCE PROMISING VACCINES. ESSENTIAL MATERNAL HEALTH MEDICINES CAN PREVENT OR TREAT THE LEADING CAUSES OF MATERNAL DEATHS. IN 2012, PATH DEVELOPED A TARGETED POLICY AGENDA FOR GLOBAL AND NATIONAL DECISION-MAKERS TO INCREASE WOMEN'S ACCESS TO THESE MEDICINES.IN ADDITION, THROUGH A UNIQUE PUBLIC-PRIVATE COLLABORATION WITH THE PHARMACEUTICAL COMPANY MERCK, WE IDENTIFIED AND ASSESSED NEARLY 40 TOOLS AND TECHNOLOGIES WITH THE POTENTIAL TO PREVENT DEATHS FROM COMPLICATIONS DURING PREGNANCY AND CHILDBIRTH. FINDINGS AND RECOMMENDATIONS HAVE BEEN MADE AVAILABLE TO DONORS, NATIONAL GOVERNMENTS, BUSINESSES, AND OTHER GROUPS, AND MAY HELP THEM MAKE SMART INVESTMENTS IN MATERNAL HEALTH PRODUCTS AND RESEARCH. TO IMPROVE NUTRITION, WE WORKED WITH THE UNIVERSITY OF WASHINGTON AND THE HUMAN MILK BANKING ASSOCIATION OF SOUTH AFRICA TO DEVELOP A LOW-COST SYSTEM THAT USES MOBILE PHONES TO MANAGE PASTEURIZATION OF DONATED BREAST MILK, AN ESSENTIAL SOURCE OF NUTRITION FOR INFANTS WHEN THEIR MOTHERS' MILK IS UNAVAILABLE.WE ALSO HELPED DEVELOP INNOVATIVE DISTRIBUTION MODELS TO INCREASE ACCESS TO RICE FORTIFIED WITH VITAMINS AND MINERALS USING THE ULTRA RICE FORTIFICATION TECHNOLOGY, ADVANCED BY PATH AND TRADEMARKED BY BON DENTE INTERNATIONAL, INC. FORTIFIED GRAINS ARE BEING INTEGRATED INTO LARGE-SCALE FOOD ASSISTANCE PROGRAMS IN BURUNDI AND CAMBODIA, COMMERCIAL RETAIL CHANNELS IN BRAZIL, AND SMALL-SCALE DISTRIBUTION CHANNELS IN VIETNAM. IN INDIA, WE HELPED ESTABLISH HIGH-QUALITY MANUFACTURING OF FORTIFIED GRAINS FOR A WORLD FOOD PROGRAMME PILOT PROJECT THAT WILL REACH 98,000 CHILDREN IN 2013.IN ADDITION, WE RENEWED OUR COMMITMENT TO COMBATING DIARRHEAL DISEASE AND PNEUMONIA, THE LEADING CAUSES OF CHILD DEATH WORLDWIDE. IN CAMBODIA, CONVINCING RESULTS FROM AN INTEGRATED APPROACH TO TREAT DIARRHEAL DISEASE AND PNEUMONIA LED TO ACCELERATED NATIONAL SCALE-UP, WITH PLANS TO REACH MORE THAN 1.6 MILLION CHILDREN BY 2014. IN ONE RURAL DISTRICT, CASES DROPPED DRAMATICALLY AFTER WE TRAINED HEALTH WORKERS AND PARENTS TO RECOGNIZE AND TREAT BOTH THREATS. OUR VACCINE DEVELOPMENT PROGRAM WORKED WITH AN INDIAN BIOTECHNOLOGY GROUP TO CONDUCT A PHASE 3 EFFICACY TRIAL OF A NEW VACCINE AGAINST ROTAVIRUS, ONE OF THE LEADING CAUSES OF SEVERE AND LIFE-THREATENING DIARRHEA AMONG CHILDREN. AND OUR PHASE 1 TRIAL OF A WHOLE-CELL VACCINE CANDIDATE DEVELOPED WITH PARTNERS AGAINST THE MOST COMMON CAUSE OF SEVERE PNEUMONIA YIELDED PROMISING RESULTS THAT SUPPORT CONTINUING CLINICAL DEVELOPMENT AND RESEARCH.IN KENYA, FAMILIES HAVE NEW, OVER-THE-COUNTER ACCESS TO ZINC, WHICH CAN CUT THE DURATION AND SEVERITY OF DIARRHEA. WE ARE WORKING WITH PROVINCIAL AND DISTRICT LEADERS TO ENSURE THIS NATIONAL POLICY CHANGE TRANSLATES INTO BROADER COMMUNITY ACCESS AND FEWER DEATHS.ADDITIONALLY, OUR INVESTIGATIONAL NEW DRUG TO TREAT ACUTE SECRETORY DIARRHEA IS SET TO PROCEED INTO THE NEXT ROUND OF STUDIES FOLLOWING THE SUCCESSFUL COMPLETION OF TWO PHASE 1 CLINICAL STUDIES IN THE UNITED STATES. THE TREATMENT COULD BECOME THE FIRST SYNTHETIC DRUG OF ITS KIND TO REDUCE FLUID LOSS, SHORTENING THE DURATION AND SEVERITY OF SYMPTOMS. | |
| 11683815 | 3460015 | REPRODUCTIVE HEALTH:PATH WORKS TO IMPROVE REPRODUCTIVE HEALTH BY STRENGTHENING ACCESS TO FAMILY PLANNING, IMPROVING SCREENING AND TREATMENT FOR CERVICAL AND BREAST CANCERS, PREVENTING SEXUALLY TRANSMITTED INFECTIONS, ADVOCATING FOR SERVICES AND SUPPLIES, INTRODUCING CONTRACEPTIVE TECHNOLOGIES, AND ENCOURAGING HEALTHY BEHAVIORS. KEY EFFORTS TO INCREASE CONTRACEPTIVE CHOICE AND ACCESS IN 2012 INCLUDED A PROJECT PAVING THE WAY FOR A NEW PACKAGING AND PRESENTATION OF A POPULAR INJECTABLE CONTRACEPTIVE. THE PRODUCT IS ADAPTED FOR DELIVERY IN THE UNIJECT INJECTION SYSTEM, DEVELOPED BY PATH AND TRADEMARKED BY BD. THE MEDICATION IS CONTAINED IN A PREFILLED PLASTIC BUBBLE FOR EASY DELIVERY, POTENTIALLY EXPANDING THE CADRE OF HEALTH WORKERS WHO CAN PROVIDE INJECTIONS. PATH HELPED LEAD RESEARCH IN AFRICA AND COORDINATED PILOT INTRODUCTION PLANNING AMONG GLOBAL AND COUNTRY PARTNERS. THE PRODUCT MAY PROVIDE NEW OPTIONS TO THE ESTIMATED 215 MILLION WOMEN WHO WANT TO PREVENT PREGNANCY BUT DO NOT USE OR HAVE ACCESS TO MODERN FAMILY PLANNING METHODS.PATH ALSO SERVED AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION, A GLOBAL PARTNERSHIP OF PUBLIC, PRIVATE, AND NONGOVERNMENTAL ORGANIZATIONS WORKING TO EXPAND ACCESS TO SUPPLIES, SERVICES, AND OPTIONS FOR PREVENTING UNINTENDED PREGNANCIES AND SEXUALLY TRANSMITTED INFECTIONS.AS PART OF ONGOING WORK TO ADDRESS THE GROWING BURDEN OF WOMEN'S CANCERS IN DEVELOPING COUNTRIES, WE PILOTED A COMMUNITY BREAST HEALTH PROJECT IN PERU THAT SCREENED MORE THAN 5,800 WOMEN FOR BREAST CANCER AND TRAINED DOZENS OF HEALTH PROVIDERS. A PLANNED EXPANSION TO ADDITIONAL AREAS IN 2013 WILL BRING THIS SERVICE TO EVEN MORE WOMEN.IN ADDITION, PATH'S EXPERIENCE INTRODUCING A VACCINE TO PREVENT HUMAN PAPILLOMAVIRUS (HPV), THE CAUSE OF CERVICAL CANCER, IN FOUR COUNTRIES LED TO THE DEVELOPMENT OF A SET OF PLANNING TOOLS THAT HAVE NOW BEEN USED BY GOVERNMENTS IN AFRICA, ASIA, AND LATIN AMERICA TO PREVENT FUTURE DEATHS FROM CERVICAL CANCER. | 4123 |
| 4251880 | 1667598 | CROSS-PROGRAM IMPACT INITIATIVES:PATH'S BROAD BASE OF EXPERTISE, EXPERIENCE, AND CAPACITY SPANS PROGRAMS AND STAFF IN MORE THAN 70 COUNTRIES. IN 2012, WE BEGAN A FORMAL STRATEGY TO INTEGRATE, COORDINATE, AND LEVERAGE THESE RESOURCES TO MAXIMIZE OUR IMPACT. WE BEGAN BY DEVELOPING CROSS-PROGRAM INITIATIVES RELATED TO PRIORITY HEALTH AREAS, INCLUDING MATERNAL AND NEONATAL HEALTH TECHNOLOGIES, DIARRHEAL DISEASE, AND PNEUMONIA. FUTURE PRIORITY HEALTH AREAS WILL INCLUDE MALARIA AND FAMILY PLANNING. | 1687 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Other Program Service Exp | 31342403 | TotalOfOtherProgramServiceExp |
| Total Of Other Program Service Grnt | 7367824 | TotalOfOtherProgramServiceGrnt |
| Total Of Other Program Service Rev | 5810 | TotalOfOtherProgramServiceRev |
| Total Program Service Expense | 233756932 | TotalProgramServiceExpense |
| Described In501 C3 | 1 | DescribedIn501C3 |
| Schedule B Required | 1 | ScheduleBRequired |
| Political Activities | 0 | PoliticalActivities |
| Lobbying Activities | 1 | LobbyingActivities |
| Subject To Proxy Tax | 0 | SubjectToProxyTax |
| Donor Advised Funds | 0 | DonorAdvisedFunds |
| Conservation Easements | 0 | ConservationEasements |
| Collections Of Art | 0 | CollectionsOfArt |
| Credit Counseling | 0 | CreditCounseling |
| Term Or Permanent Endowments | 1 | TermOrPermanentEndowments |
| Report Land Bldg Equip | 1 | ReportLandBldgEquip |
| Report Invest Oth Securities | 0 | ReportInvestOthSecurities |
| Report Prog Rel Invest | 0 | ReportProgRelInvest |
| Report Other Assets | 0 | ReportOtherAssets |
| Report Other Liabilities | 0 | ReportOtherLiabilities |
| Report Fin48 Footnote | 0 | ReportFin48Footnote |
| Independent Audit Financial Stmt | 0 | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | 1 | ConsolidatedAuditFinancialStmt |
| School | 0 | School |
| Foreign Office | 1 | ForeignOffice |
| Foreign Activities | 1 | ForeignActivities |
| More Than5000 K To Organizations | 1 | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividuals |
| Professional Fundraising | 0 | ProfessionalFundraising |
| Fundraising Activities | 0 | FundraisingActivities |
| Gaming | 0 | Gaming |
| Hospital | 0 | Hospital |
| Grants To Organizations | 1 | GrantsToOrganizations |
| Grants To Individuals | 0 | GrantsToIndividuals |
| Schedule J Required | 1 | ScheduleJRequired |
| Tax Exempt Bonds | 0 | TaxExemptBonds |
| Excess Benefit Transaction | 0 | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | 0 | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | 0 | LoanToOfficerOrDQP |
| Grant To Related Person | 0 | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | 0 | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | 0 | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | 0 | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | 1 | DeductibleNonCashContributions |
| Deductible Contributions Of Art | 0 | DeductibleContributionsOfArt |
| Terminated | 0 | Terminated |
| Partial Liquidation | 0 | PartialLiquidation |
| Disregarded Entity | 0 | DisregardedEntity |
| Related Entity | 1 | RelatedEntity |
| Related Org Controlled Entity | 1 | RelatedOrgControlledEntity |
| Transaction Related Entity | 1 | TransactionRelatedEntity |
| Transfers To Exempt Non Chrtbl Org | 0 | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | 0 | ActivitiesConductedPartnership |
| Schedule O Required | 1 | ScheduleORequired |
| Info In Schedule O Part V | X | InfoInScheduleOPartV |
| Number Forms Transmitted With1096 | 218 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 0 | NumberW2GIncluded |
| Compliance With Backup Witholding | 1 | ComplianceWithBackupWitholding |
| Number Of Employees | 646 | NumberOfEmployees |
| Employment Tax Returns Filed | 1 | EmploymentTaxReturnsFiled |
| Unrelated Business Income | 0 | UnrelatedBusinessIncome |
| Foreign Financial Account | 1 | ForeignFinancialAccount |
| Name Of Foreign Country | BE | NameOfForeignCountry |
| Name Of Foreign Country | CB | NameOfForeignCountry |
| Name Of Foreign Country | CH | NameOfForeignCountry |
| Name Of Foreign Country | CG | NameOfForeignCountry |
| Name Of Foreign Country | ET | NameOfForeignCountry |
| Name Of Foreign Country | FR | NameOfForeignCountry |
| Name Of Foreign Country | GH | NameOfForeignCountry |
| Name Of Foreign Country | IN | NameOfForeignCountry |
| Name Of Foreign Country | IV | NameOfForeignCountry |
| Name Of Foreign Country | KE | NameOfForeignCountry |
| Name Of Foreign Country | NU | NameOfForeignCountry |
| Name Of Foreign Country | PE | NameOfForeignCountry |
| Name Of Foreign Country | SG | NameOfForeignCountry |
| Name Of Foreign Country | SF | NameOfForeignCountry |
| Name Of Foreign Country | TZ | NameOfForeignCountry |
| Name Of Foreign Country | TH | NameOfForeignCountry |
| Name Of Foreign Country | UG | NameOfForeignCountry |
| Name Of Foreign Country | UP | NameOfForeignCountry |
| Name Of Foreign Country | VM | NameOfForeignCountry |
| Name Of Foreign Country | ZA | NameOfForeignCountry |
| Name Of Foreign Country | MI | NameOfForeignCountry |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTrans |
| Taxable Party Notification | 0 | TaxablePartyNotification |
| Non Deductible Contributions | 0 | NonDeductibleContributions |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributions |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOf |
| Funds To Pay Premiums | 0 | FundsToPayPremiums |
| Premiums Paid | 0 | PremiumsPaid |
| Indoor Tanning Services | 0 | IndoorTanningServices |
| Info In Schedule O Part VI | X | InfoInScheduleOPartVI |
| Nbr Voting Governing Body Members | 11 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 11 | NumberIndependentVotingMembers |
| Family Or Business Relationship | 0 | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | 0 | DelegationOfManagementDuties |
| Changes To Organizing Docs | 0 | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuse |
| Members Or Stockholders | 0 | MembersOrStockholders |
| Election Of Board Members | 0 | ElectionOfBoardMembers |
| Decisions Subject To Approval | 0 | DecisionsSubjectToApproval |
| Minutes Of Governing Body | 1 | MinutesOfGoverningBody |
| Minutes Of Committees | 1 | MinutesOfCommittees |
| Officer Mailing Address | 0 | OfficerMailingAddress |
| Local Chapters | 0 | LocalChapters |
| Form990 Provided To Governing Body | 1 | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | 1 | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | 1 | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | 1 | RegularMonitoringEnforcement |
| Whistleblower Policy | 1 | WhistleblowerPolicy |
| Document Retention Policy | 1 | DocumentRetentionPolicy |
| Compensation Process CEO | 1 | CompensationProcessCEO |
| Compensation Process Other | 1 | CompensationProcessOther |
| Investment In Joint Venture | 0 | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | AZ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | FL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MD | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NJ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | TX | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WA | StatesWhereCopyOfReturnIsFiled |
| Own Website | X | OwnWebsite |
| Other Website | X | OtherWebsite |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
Name Business NameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | OLIVIA POLIUS CHIEF FINANCIAL OFFICER | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Telephone Number | 2062853500 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2201 WESTLAKE AVE SUITE 200 | AddressLine1 |
| City | SEATTLE | City |
| State | WA | State |
| ZIP Code | 98121 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionA (39 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Average Hours Per Week RelatedAverageHoursPerWeekRelated | Individual Trustee Or DirectorIndividualTrusteeOrDirector | OfficerOfficer | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | Key EmployeeKeyEmployee | Highest Compensated EmployeeHighestCompensatedEmployee |
|---|---|---|---|---|---|---|---|---|---|
| MOLLY JOEL COYE | |||||||||
| BOARD CHAIR | 2.00 | 0.00 | X | X | 0 | 0 | 0 | ||
| VINCENT MCGEE | |||||||||
| BOARD VICE CHAIR | 2.00 | 0.00 | X | X | 0 | 0 | 0 | ||
| DEAN ALLEN | |||||||||
| BOARD TREASURER | 2.00 | 0.00 | X | X | 0 | 0 | 0 | ||
| JAY SATIA | |||||||||
| BOARD SECRETARY | 2.00 | 0.00 | X | X | 0 | 0 | 0 | ||
| ALEX CHIKA EZEH | |||||||||
| DIRECTOR | 2.00 | 0.00 | X | 0 | 0 | 0 | |||
| EIVOR HALKJAER | |||||||||
| DIRECTOR | 2.00 | 0.00 | X | 0 | 0 | 0 | |||
| GEORGE GOTSADZE | |||||||||
| DIRECTOR | 2.00 | 0.00 | X | 0 | 0 | 0 | |||
| KEVIN REILLY | |||||||||
| DIRECTOR | 2.00 | 0.00 | X | 0 | 0 | 0 | |||
| PHYLLIS CAMPBELL | |||||||||
| DIRECTOR | 2.00 | 0.00 | X | 0 | 0 | 0 | |||
| SUPAMIT CHUNSUTTIWAT | |||||||||
| DIRECTOR | 2.00 | 0.00 | X | 0 | 0 | 0 | |||
| WOODROW MYERS | |||||||||
| DIRECTOR | 2.00 | 0.00 | X | 0 | 0 | 0 | |||
| CHRISTOPHER J ELIAS | |||||||||
| PRESIDENT AND CEO (UNTIL 1/31/12) | 36.00 | 4.00 | X | 223504 | 0 | 12905 | |||
| STEVEN B DAVIS | |||||||||
| PRESIDENT AND CEO (BEGAN 6/1/12) | 36.00 | 4.00 | X | 215600 | 0 | 19353 | |||
| ERIC G WALKER | |||||||||
| VP, CORPORATE SERVICES | 36.00 | 4.00 | X | 252022 | 0 | 37003 | |||
| AYORINDE ARNOLD AJAYI | |||||||||
| VP, INTERNATIONAL DEVELOPMENT | 40.00 | 0.00 | 260390 | 0 | 35796 | X | |||
| CARLOS CLINTON CAMPBELL | |||||||||
| DIR., MALARIA CONTROL PROGRAM | 40.00 | 0.00 | 199238 | 0 | 21797 | X | |||
| CATHARINE HOWARD TAYLOR | |||||||||
| GLOBAL PROGRAM LEADER, MCHN | 40.00 | 0.00 | 204790 | 0 | 32180 | X | |||
| DANIEL LASTER | |||||||||
| GENERAL COUNSEL | 37.00 | 3.00 | 215725 | 0 | 34457 | X | |||
| DAVID C KASLOW | |||||||||
| MVI PROGRAM LEADER | 40.00 | 0.00 | 267606 | 0 | 26959 | X | |||
| ERIC A ARNOLD | |||||||||
| CHIEF INFORMATION OFFICER | 40.00 | 0.00 | 201899 | 0 | 34636 | X | |||
| JACQUELINE D SHERRIS | |||||||||
| VP, PUBLIC HEALTH IMPACT | 37.00 | 3.00 | 260690 | 0 | 30493 | X | |||
| JANE E HUTCHINGS | |||||||||
| DIRECTOR, REPRODUCTIVE HEALTH | 40.00 | 0.00 | 188006 | 0 | 32426 | X | |||
| JOAN LITTLEFIELD | |||||||||
| COUNTRY PROGRAM LEADER, ZAMBIA | 40.00 | 0.00 | 201776 | 0 | 22644 | X | |||
| JOHN W BOSLEGO | |||||||||
| DIR, VACCINE DEV. GLOBAL PROGRAM | 40.00 | 0.00 | 330915 | 0 | 38973 | X | |||
| JULIE M PULERWITZ | |||||||||
| DIR, HIV/AIDS & TB GLOBAL PROG. | 40.00 | 0.00 | 177897 | 0 | 30009 | X | |||
| KATHLEEN M NEUZIL | |||||||||
| GLOBAL PROGRAM LEADER, VAD | 40.00 | 0.00 | 221576 | 0 | 33469 | X | |||
| KATHRYN A O'DRISCOLL | |||||||||
| CHIEF HUMAN RESOURCES OFFICER | 40.00 | 0.00 | 197574 | 0 | 29643 | X | |||
| MARLOW KEE | |||||||||
| CHIEF FINANCIAL OFFICER | 36.00 | 4.00 | 203571 | 0 | 33892 | X | |||
| MICHAEL J FREE | |||||||||
| VP & SR. ADVISOR FOR TECHNOLOGIES | 40.00 | 0.00 | 217699 | 0 | 36451 | X | |||
| MICHELLE FOLSOM | |||||||||
| DIRECTOR, PROGRAM DEVELOPMENT | 40.00 | 0.00 | 171441 | 0 | 28104 | X | |||
| RACHEL WILSON | |||||||||
| SENIOR DIRECTOR, POLICY & ADVOCACY | 40.00 | 0.00 | 176461 | 0 | 30427 | X | |||
| RAMONA ANNE BYRKIT | |||||||||
| COUNTRY PROG. LEADER, VIETMAN | 40.00 | 0.00 | 219723 | 0 | 25034 | X | |||
| RIKKA E TRANGSRUD | |||||||||
| COUNTRY PROGRAM LEADER, KENYA | 40.00 | 0.00 | 226667 | 0 | 27557 | X | |||
| SARAH C TEMPLE | |||||||||
| VP, EXTERNAL RELATIONS | 40.00 | 0.00 | 211095 | 0 | 24001 | X | |||
| ASHLEY BIRKETT | |||||||||
| DIRECTOR, RESEARCH & DEVELOPMENT | 40.00 | 0.00 | 232766 | 0 | 36184 | X | |||
| DUNCAN OWENS EARLE | |||||||||
| PROG. DIR., MALARIA CONTROL & EVAL. | 40.00 | 0.00 | 257329 | 0 | 33389 | X | |||
| JEAN A NTUMBA BIDUAYA | |||||||||
| FINANCE & ADMIN. SPEC., HIV & TB | 40.00 | 0.00 | 239389 | 0 | 18139 | X | |||
| JOHN SKIBIAK | |||||||||
| DIRECTOR, RHSC | 40.00 | 0.00 | 344504 | 0 | 31676 | X | |||
| TRAD M HATTON | |||||||||
| CHIEF OF PARTY, INTEGRATED HIV/AIDS | 40.00 | 0.00 | 231603 | 0 | 22803 | X | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 6351456 | TotalReportableCompFromOrg |
| Total Reportable Comp Frm Rltd Orgs | 0 | TotalReportableCompFrmRltdOrgs |
| Total Other Compensation | 820400 | TotalOtherCompensation |
| Number Individuals GT100 K | 177 | NumberIndividualsGT100K |
| Formers Listed | 0 | FormersListed |
| Total Comp GT150 K | 1 | TotalCompGT150K |
| Compensation From Other Sources | 0 | CompensationFromOtherSources |
Contractor Compensation ContractorCompensation (5 entries)
| Address Line1AddressOfContractor/AddressUS/AddressLine1 | CityAddressOfContractor/AddressUS/City | StateAddressOfContractor/AddressUS/State | ZIP CodeAddressOfContractor/AddressUS/ZIPCode | Description Of ServicesDescriptionOfServices | CompensationCompensation |
|---|---|---|---|---|---|
| SLALOM LLC | |||||
| 821 2ND AVE STE 1900 | SEATTLE | WA | 98124 | GENERAL CONTRACTOR | 1206709 |
| WIDENET CONSULTING GROUP | |||||
| 11400 SE 6TH ST | BELLEVUE | WA | 98004 | GENERAL CONTRACTOR | 671283 |
| NORTHERN TRUST | |||||
| 50 S LASALLE ST | CHICAGO | IL | 60675 | ASSET MANAGEMENT | 563300 |
| COMMERICIAL OFFICE INTERIORS | |||||
| 2601 4TH AVE STE 700 | SEATTLE | WA | 98121 | GENERAL CONTRACTOR | 470091 |
| CLARK NUBER & CO | |||||
| 10900 NE 4TH STREET 1700 | BELLEVUE | WA | 98004 | ACCOUNTING SERVICES | 266992 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Number Of Contractors GT100 K | 13 | NumberOfContractorsGT100K |
| Related Organizations | 17915569 | RelatedOrganizations |
| Government Grants | 117500057 | GovernmentGrants |
| All Other Contributions | 36121243 | AllOtherContributions |
| Noncash Contributions | 197437 | NoncashContributions |
| Total Contributions | 171536869 | TotalContributions |
Program Service Revenue ProgramServiceRevenue (2 entries)
| DescriptionDescription | Business CodeBusinessCode | Total Revenue ColumnTotalRevenueColumn | Related Or Exempt Function IncomeRelatedOrExemptFunctionIncome |
|---|---|---|---|
| HONORARIUM | 900099 | 23285 | 23285 |
| SALES | 900099 | 4007 | 4007 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | 27292 | TotalProgramServiceRevenue |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 2286568 | TotalRevenueColumn |
| Exclusion | $2,286,568 | ExclusionAmount |
Royalties Revenue RoyaltiesRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 8885 | TotalRevenueColumn |
| Exclusion | $8,885 | ExclusionAmount |
Gross Amount Sales Assets GrossAmountSalesAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 73961000 | Securities |
| Other | 1940657 | Other |
Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 73416794 | Securities |
| Other | 2094024 | Other |
Gain Or Loss GainOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 544206 | Securities |
| Other | -153367 | Other |
Net Gain Or Loss Investments NetGainOrLossInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 390839 | TotalRevenueColumn |
| Exclusion | $390,839 | ExclusionAmount |
Other Revenue Misc OtherRevenueMisc (3 entries)
| DescriptionDescription | Business CodeBusinessCode | Total Revenue ColumnTotalRevenueColumn | ExclusionExclusionAmount |
|---|---|---|---|
| GAIN-FOREIGN EXCH. | 900099 | 379889 | $379,889 |
| REIMBURSEMENTS | 900099 | 271965 | $271,965 |
| OTHER | 900099 | 78888 | $78,888 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Revenue | 730742 | TotalOtherRevenue |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 174981195 | TotalRevenueColumn |
| Related Or Exempt Function Income | 27292 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | 0 | UnrelatedBusinessRevenue |
| Exclusion | $3,417,034 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 29604090 | Total |
| Program Services | 29604090 | ProgramServices |
Foreign Grants ForeignGrants
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 40794325 | Total |
| Program Services | 40794325 | ProgramServices |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 6103550 | Total |
| Program Services | 3993078 | ProgramServices |
| Management And General | 2102861 | ManagementAndGeneral |
| Fundraising | 7611 | Fundraising |
Other Salaries And Wages OtherSalariesAndWages
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 64128607 | Total |
| Program Services | 38409258 | ProgramServices |
| Management And General | 25066685 | ManagementAndGeneral |
| Fundraising | 652664 | Fundraising |
Pension Plan Contributions PensionPlanContributions
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 6124903 | Total |
| Management And General | 6124903 | ManagementAndGeneral |
Other Employee Benefits OtherEmployeeBenefits
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 8740082 | Total |
| Program Services | 824534 | ProgramServices |
| Management And General | 7915548 | ManagementAndGeneral |
Payroll Taxes PayrollTaxes
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 5588162 | Total |
| Program Services | 385915 | ProgramServices |
| Management And General | 5202247 | ManagementAndGeneral |
Fees For Services Legal FeesForServicesLegal
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 544901 | Total |
| Program Services | 180200 | ProgramServices |
| Management And General | 364701 | ManagementAndGeneral |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 427015 | Total |
| Program Services | 30927 | ProgramServices |
| Management And General | 396088 | ManagementAndGeneral |
Fees For Services Lobbying FeesForServicesLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 115999 | Total |
| Program Services | 24000 | ProgramServices |
| Management And General | 91999 | ManagementAndGeneral |
Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 421309 | Total |
| Management And General | 421309 | ManagementAndGeneral |
Fees For Services Other FeesForServicesOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 10973529 | Total |
| Program Services | 6718913 | ProgramServices |
| Management And General | 4192049 | ManagementAndGeneral |
| Fundraising | 62567 | Fundraising |
Advertising Advertising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 251243 | Total |
| Program Services | 200277 | ProgramServices |
| Management And General | 49041 | ManagementAndGeneral |
| Fundraising | 1925 | Fundraising |
Office Expenses OfficeExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 5885767 | Total |
| Program Services | 4607107 | ProgramServices |
| Management And General | 1231586 | ManagementAndGeneral |
| Fundraising | 47074 | Fundraising |
Information Technology InformationTechnology
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 897714 | Total |
| Program Services | 317336 | ProgramServices |
| Management And General | 538776 | ManagementAndGeneral |
| Fundraising | 41602 | Fundraising |
Royalties Royalties
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 71279 | Total |
| Program Services | 71279 | ProgramServices |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 9376412 | Total |
| Program Services | 1251716 | ProgramServices |
| Management And General | 8124696 | ManagementAndGeneral |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 20717871 | Total |
| Program Services | 18408831 | ProgramServices |
| Management And General | 2300980 | ManagementAndGeneral |
| Fundraising | 8060 | Fundraising |
Conferences Meetings ConferencesMeetings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 9259925 | Total |
| Program Services | 8675300 | ProgramServices |
| Management And General | 475997 | ManagementAndGeneral |
| Fundraising | 108628 | Fundraising |
Interest Interest
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 101664 | Total |
| Management And General | 101664 | ManagementAndGeneral |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2884236 | Total |
| Program Services | 179178 | ProgramServices |
| Management And General | 2705058 | ManagementAndGeneral |
Insurance Insurance
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 486748 | Total |
| Program Services | 182165 | ProgramServices |
| Management And General | 304583 | ManagementAndGeneral |
Other Expenses OtherExpenses (4 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | Management And GeneralManagementAndGeneral | FundraisingFundraising |
|---|---|---|---|---|
| SUBCONTRACTS | 40311864 | 39900585 | 411279 | |
| EQUIP RENT & MAINT | 4503634 | 3178422 | 1310396 | 14816 |
| FACILITIES ALLOC | 0 | 9063437 | -9299229 | 235792 |
| LEAVE & BENS ALLOC | 0 | 21468156 | -21812606 | 344450 |
All Other Expenses AllOtherExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 6031777 | Total |
| Program Services | 5287903 | ProgramServices |
| Management And General | 740606 | ManagementAndGeneral |
| Fundraising | 3268 | Fundraising |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 274346606 | Total |
| Program Services | 233756932 | ProgramServices |
| Management And General | 39061217 | ManagementAndGeneral |
| Fundraising | 1528457 | Fundraising |
Cash Non Interest Bearing CashNonInterestBearing
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 7282495 | BOY |
| EOY | 5456357 | EOY |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3303751 | BOY |
| EOY | 7755742 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 336128128 | BOY |
| EOY | 267202359 | EOY |
Accounts Receivable AccountsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 9125399 | BOY |
| EOY | 7835110 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2606825 | BOY |
| EOY | 2621049 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 32986562 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 12627304 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 22080136 | BOY |
| EOY | 20359258 | EOY |
Investments Pub Traded Securities InvestmentsPubTradedSecurities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 231566492 | BOY |
| EOY | 196097539 | EOY |
Intangible Assets IntangibleAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 582329 | BOY |
| EOY | 403151 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 612675555 | BOY |
| EOY | 507730565 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 60627756 | BOY |
| EOY | 53959115 | EOY |
Mort Notes Pybl Secured Invest Prop MortNotesPyblSecuredInvestProp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 5980164 | BOY |
| EOY | 5232299 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 66607920 | BOY |
| EOY | 59191414 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Follow SFAS117 | X | FollowSFAS117 |
Unrestricted Net Assets UnrestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 17628634 | BOY |
| EOY | 20660464 | EOY |
Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 525069348 | BOY |
| EOY | 424503642 | EOY |
Permanently Restricted Net Assets PermanentlyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3369653 | BOY |
| EOY | 3375045 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 546067635 | BOY |
| EOY | 448539151 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 612675555 | BOY |
| EOY | 507730565 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expenses | -99365411 | ReconcilationRevenueExpenses |
| Reconciliation Unrealized Invest | 1836927 | ReconciliationUnrealizedInvest |
| Reconcilation Other Changes | 0 | ReconcilationOtherChanges |
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | 0 | AccountantCompileOrReview |
| FS Audited | 1 | FSAudited |
FS Audited Basis FSAuditedBasis
| Field | Value | IRS element (for citing) |
|---|---|---|
| Financial Statement Consolidated | X | FinancialStatementConsolidated |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | 1 | AuditCommittee |
| Federal Grant Audit Required | 1 | FederalGrantAuditRequired |
| Federal Grant Audit Performed | 1 | FederalGrantAuditPerformed |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org170b1 Avi | X | PubliclySupportedOrg170b1Avi |
Gifts Grants Contrib Received170 GiftsGrantsContribReceived170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 270187073 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 257511086 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 152434405 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 240628741 | CurrentTaxYearMinus1Year |
| Current Tax Year | 171536869 | CurrentTaxYear |
| Total | 1092298174 | Total |
Total170 Total170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 270187073 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 257511086 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 152434405 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 240628741 | CurrentTaxYearMinus1Year |
| Current Tax Year | 171536869 | CurrentTaxYear |
| Total | 1092298174 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Amounts Subst Contributors Total | 404214642 | AmountsSubstContributorsTotal |
| Public Support Total170 | 688083532 | PublicSupportTotal170 |
Gross Investment Income170 GrossInvestmentIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 9272569 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 5825631 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 4380066 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 2797154 | CurrentTaxYearMinus1Year |
| Current Tax Year | 2295453 | CurrentTaxYear |
| Total | 24570873 | Total |
Other Income170 OtherIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 483060 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 524296 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 1557958 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 502596 | CurrentTaxYearMinus1Year |
| Current Tax Year | 730742 | CurrentTaxYear |
| Total | 3798652 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | 1120667699 | TotalSupport |
| Gross Receipts From Admissions Etc | 316422 | GrossReceiptsFromAdmissionsEtc |
| Public Support Pertcentage170 | 0.61400 | PublicSupportPertcentage170 |
| Public Support Pertcent Prior Year | 0.55080 | PublicSupportPertcentPriorYear |
| Thirty Three Percnt Tests CY170 | X | ThirtyThreePercntTestsCY170 |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule C IRS990ScheduleC
Total Grassroots Lobbying TotalGrassrootsLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 0 | FilingOrganizationsTotals |
Total Direct Lobbying TotalDirectLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 193545 | FilingOrganizationsTotals |
Total Lobbying Expenditures TotalLobbyingExpenditures
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 193545 | FilingOrganizationsTotals |
Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 274112686 | FilingOrganizationsTotals |
Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 274306231 | FilingOrganizationsTotals |
Lobbying Nontaxable LobbyingNontaxableAmount
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 1000000 | FilingOrganizationsTotals |
Grassroots Nontaxable GrassrootsNontaxableAmount
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 250000 | FilingOrganizationsTotals |
Tot Lobbying Grassroot Minus Non Tx TotLobbyingGrassrootMinusNonTx
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 0 | FilingOrganizationsTotals |
Tot Lobby Expend Mns Lobbying Nontx TotLobbyExpendMnsLobbyingNontx
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 0 | FilingOrganizationsTotals |
Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | 1000000 | CurrentYearMinus3 |
| Current Year Minus2 | 1000000 | CurrentYearMinus2 |
| Current Year Minus1 | 1000000 | CurrentYearMinus1 |
| Current Year | 1000000 | CurrentYear |
| Total | 4000000 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmount |
Total Lobbying Expenditures2 TotalLobbyingExpenditures2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | 195195 | CurrentYearMinus3 |
| Current Year Minus2 | 219409 | CurrentYearMinus2 |
| Current Year Minus1 | 197270 | CurrentYearMinus1 |
| Current Year | 193545 | CurrentYear |
| Total | 805419 | Total |
Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | 250000 | CurrentYearMinus3 |
| Current Year Minus2 | 250000 | CurrentYearMinus2 |
| Current Year Minus1 | 250000 | CurrentYearMinus1 |
| Current Year | 250000 | CurrentYear |
| Total | 1000000 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,000 | GrassrootsCeilingAmount |
Grassroots Lobbying Expenditures GrassrootsLobbyingExpenditures
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | 4137 | CurrentYearMinus3 |
| Current Year Minus2 | 6398 | CurrentYearMinus2 |
| Total | 10535 | Total |
Schedule D IRS990ScheduleD
Current Year CurrentYear
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 6868767 | BeginningOfYearBalance |
| Contributions | 5392 | Contributions |
| Investment Earnings Or Losses | 932627 | InvestmentEarningsOrLosses |
| End Of Year Balance | 7806786 | EndOfYearBalance |
Current Year Minus1 Year CurrentYearMinus1Year
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 6671532 | BeginningOfYearBalance |
| Contributions | 2700 | Contributions |
| Investment Earnings Or Losses | 194535 | InvestmentEarningsOrLosses |
| End Of Year Balance | 6868767 | EndOfYearBalance |
Current Year Minus2 Years CurrentYearMinus2Years
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 5943911 | BeginningOfYearBalance |
| Contributions | 1790 | Contributions |
| Investment Earnings Or Losses | 725831 | InvestmentEarningsOrLosses |
| End Of Year Balance | 6671532 | EndOfYearBalance |
Current Year Minus3 Years CurrentYearMinus3Years
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 4752059 | BeginningOfYearBalance |
| Contributions | 2039 | Contributions |
| Investment Earnings Or Losses | 1189813 | InvestmentEarningsOrLosses |
| End Of Year Balance | 5943911 | EndOfYearBalance |
Current Year Minus4 Years CurrentYearMinus4Years
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 6474476 | BeginningOfYearBalance |
| Contributions | 21290 | Contributions |
| Investment Earnings Or Losses | -1591603 | InvestmentEarningsOrLosses |
| Other Expenditures | 152104 | OtherExpenditures |
| End Of Year Balance | 4752059 | EndOfYearBalance |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated EOY Balance | 0.57000 | BoardDesignatedEOYBalance |
| Permanent Endowment EOY Balance | 0.43000 | PermanentEndowmentEOYBalance |
| Endowments Held By Unrelated Orgs | 0 | EndowmentsHeldByUnrelatedOrgs |
| Endowments Held By Related Orgs | 0 | EndowmentsHeldByRelatedOrgs |
Leasehold Improvements LeaseholdImprovements
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 19846547 | OtherCostOrOtherBasis |
| Depreciation | 4896944 | Depreciation |
| Book Value | 14949603 | BookValue |
Equipment Equipment
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 9674165 | OtherCostOrOtherBasis |
| Depreciation | 6667014 | Depreciation |
| Book Value | 3007151 | BookValue |
Other Land Buildings OtherLandBuildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 3465850 | OtherCostOrOtherBasis |
| Depreciation | 1063346 | Depreciation |
| Book Value | 2402504 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 20359258 | TotalOfBookValueLandBuildings |
Form990 Schedule D Part XIII Form990ScheduleDPartXIII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: | Identifier |
| Return Reference | PART V, LINE 4: | ReturnReference |
| Explanation | PATH UTILIZES THE INVESTED INTEREST EARNINGS FROM THE ENDOWMENT AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH, IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY. | Explanation |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 1 | GrantRecordsMaintained |
Accts Actvs Out US Table AcctsActvsOutUSTable (64 entries)
| RegionRegion | Number Of OfficesNumberOfOffices | Number Of EmployeesNumberOfEmployees | Type Of Activities ConductedTypeOfActivitiesConducted | Specific Services ProvidedSpecificServicesProvided | Total ExpendituresTotalExpenditures |
|---|---|---|---|---|---|
| CENTRAL AMERICA AND THE CARIBBEAN | 1 | 1 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | 949 |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | REPRODUCTIVE HEALTH | 368664 |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | EMERGING AND EPIDEMIC DISEASES | 218969 |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | HEALTH TECHOLOGIES | 85287 |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | VACCINES AND IMMUNIZATIONS | 148585 |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | MATERNAL & CHILD HEALTH | 221020 |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | CROSS PROGRAM | 7899 |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | GRANTMAKING | 206082 | |
| EAST ASIA AND THE PACIFIC | 4 | 61 | PROGRAM SERVICES | REPRODUCTIVE HEALTH | 765912 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | EMERGING AND EPIDEMIC DISEASES | 2491750 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | VACCINES AND IMMUNIZATIONS | 1341745 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | MATERNAL & CHILD HEALTH | 74869 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | CROSS PROGRAM | 16577 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | HEALTH TECHOLOGIES | 967341 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | 24999 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTMAKING | 6656790 | |
| EUROPE | 2 | 26 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | 1053 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | CROSS PROGRAM | 16307 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | EMERGING AND EPIDEMIC DISEASES | 3294076 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | HEALTH TECHOLOGIES | 797781 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | MATERNAL & CHILD HEALTH | 517919 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | REPRODUCTIVE HEALTH | 1588391 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | VACCINES AND IMMUNIZATIONS | 9366544 |
| EUROPE | 0 | 0 | GRANTMAKING | 10510893 | |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | 14765 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | PROGRAM SERVICES | MATERNAL & CHILD HEALTH | 38703 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | PROGRAM SERVICES | VACCINCES AND IMMUNIZATIONS | 71114 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | PROGRAM SERVICES | CROSS PROGRAMS | 991 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | GRANTMAKING | 44603 | |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | EMERGING AND EPIDEMIC DISEASES | 230736 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | HEALTH TECHOLOGIES | 63517 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | MATERNAL & CHILD HEALTH | 19153 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | REPRODUCTIVE HEALTH | 14752 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | VACCINES AND IMMUNIZATIONS | 230057 |
| RUSSIA AND THE NEWLY INDEPENDENT STATES | 1 | 1 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | 543 |
| RUSSIA AND THE NEWLY INDEPENDENT STATES | 0 | 0 | PROGRAM SERVICES | EMERGING AND EPIDEMIC DISEASES | 1176357 |
| RUSSIA AND THE NEWLY INDEPENDENT STATES | 0 | 0 | PROGRAM SERVICES | HEALTH TECHOLOGIES | 1780 |
| RUSSIA AND THE NEWLY INDEPENDENT STATES | 0 | 0 | PROGRAM SERVICES | REPRODUCTIVE HEALTH | 2203 |
| RUSSIA AND THE NEWLY INDEPENDENT STATES | 0 | 0 | PROGRAM SERVICES | VACCINES AND IMMUNIZATIONS | 109000 |
| RUSSIA AND THE NEWLY INDEPENDENT STATES | 0 | 0 | GRANTMAKING | 1223358 | |
| SOUTH AMERICA | 1 | 2 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | 400 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | EMERGING AND EPIDEMIC DISEASES | 23620 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | HEALTH TECHOLOGIES | 34239 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | MATERNAL & CHILD HEALTH | 151232 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | REPRODUCTIVE HEALTH | 123488 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | VACCINES AND IMMUNIZATIONS | 1723 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | CROSS PROGRAM | 1060 |
| SOUTH AMERICA | 0 | 0 | GRANTMAKING | 438874 | |
| SOUTH ASIA | 7 | 79 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | 9954 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | EMERGING AND EPIDEMIC DISEASES | 1431029 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | HEALTH TECHOLOGIES | 687814 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | MATERNAL & CHILD HEALTH | 1443052 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | REPRODUCTIVE HEALTH | 377511 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | VACCINES AND IMMUNIZATIONS | 1402695 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | CROSS PROGRAM | 51585 |
| SOUTH ASIA | 0 | 0 | GRANTMAKING | 6074647 | |
| SUB-SAHARAN AFRICA | 24 | 442 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | 121533 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | CROSS PROGRAM | 134499 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | EMERGING AND EPIDEMIC DISEASES | 37533156 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | HEALTH TECHOLOGIES | 2115410 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | MATERNAL & CHILD HEALTH | 2416866 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | REPRODUCTIVE HEALTH | 1446221 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | VACCINES AND IMMUNIZATIONS | 9575120 |
| SUB-SAHARAN AFRICA | 0 | 0 | GRANTMAKING | 15639078 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Number Of Offices | 1 | SubtotalNumberOfOffices |
| Subtotal Number Of Employees | 1 | SubtotalNumberOfEmployees |
| Cont Number Of Offices | 39 | ContNumberOfOffices |
| Cont Number Of Employees | 611 | ContNumberOfEmployees |
| Total Number Of Offices | 40 | TotalNumberOfOffices |
| Total Number Of Employees | 612 | TotalNumberOfEmployees |
| Subtotal Amount Spent | 1257455 | SubtotalAmountSpent |
| Cont Amount Spent | 122909385 | ContAmountSpent |
| Total Amount Spent | 124166840 | TotalAmountSpent |
Grants To Orgs Outside US GrantsToOrgsOutsideUS (297 entries)
| RegionRegion | Purpose Of GrantPurposeOfGrant | Amount Of Cash GrantAmountOfCashGrant | Manner Of Cash DisbursementMannerOfCashDisbursement |
|---|---|---|---|
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10370 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 360282 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10213 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 11429 | CHECK/WIRE |
| SOUTH ASIA | HEALTH TECHOLOGIES | 5718 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 34424 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 47714 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 100000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 8735 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 34944 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 225565 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 17298 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 15928 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 12593 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 13946 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 19400 | CHECK/WIRE |
| SOUTH AMERICA | REPRODUCTIVE HEALTH | 100541 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | REPRODUCTIVE HEALTH | 17960 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | REPRODUCTIVE HEALTH | 21708 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | REPRODUCTIVE HEALTH | 29610 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 121240 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 112673 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 80036 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 45286 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 10015 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 16190 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 84538 | CHECK/WIRE |
| EUROPE | HEALTH TECHOLOGIES | 243364 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 19138 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 139087 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 29058 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10146 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 39386 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 50190 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 11411 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 12699 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 16404 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 5942 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 8014 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 10940 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 13281 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 8493 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 13118 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 209285 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | MATERNAL & CHILD HEALTH | 10500 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 24409 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 51818 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 29466 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 33446 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 146021 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 116774 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 25709 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 1366141 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 100675 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | VACCINES AND IMMUNIZATIONS | 250000 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 16059 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 64592 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 373886 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 15750 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10677 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 1738530 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 550000 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 369416 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 5420 | CHECK/WIRE |
| RUSSIA AND THE NEWLY INDEPENDENT STATES | VACCINES AND IMMUNIZATIONS | 21566 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 18762 | CHECK/WIRE |
| SOUTH ASIA | MATERNAL & CHILD HEALTH | 8417 | CHECK/WIRE |
| EUROPE | OVERHEAD | 9565 | CHECK/WIRE |
| SOUTH AMERICA | REPRODUCTIVE HEALTH | 6283 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 19388 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 40092 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 331235 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 38686 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 20111 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 325537 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | REPRODUCTIVE HEALTH | 15000 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 112945 | CHECK/WIRE |
| SOUTH AMERICA | HEALTH TECHOLOGIES | 39177 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | REPRODUCTIVE HEALTH | 46000 | CHECK/WIRE |
| SOUTH AMERICA | MATERNAL & CHILD HEALTH | 18629 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 19496 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 11526 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 1127984 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 351633 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 17158 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 171027 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 5693 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 17541 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 73000 | CHECK/WIRE |
| SOUTH ASIA | HEALTH TECHOLOGIES | 20000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 45815 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | VACCINES AND IMMUNIZATIONS | 6851 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 17302 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 92189 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 30757 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 11370 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 55125 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 356314 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 50000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 81287 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 2256432 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 88090 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 22141 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 271505 | CHECK/WIRE |
| EUROPE | REPRODUCTIVE HEALTH | 7707 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 21000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 19305 | CHECK/WIRE |
| EUROPE | MATERNAL & CHILD HEALTH | 225000 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 318817 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 251494 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 119216 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 28580 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 66689 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 19972 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 26180 | CHECK/WIRE |
| SOUTH ASIA | REPRODUCTIVE HEALTH | 10015 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | VACCINES AND IMMUNIZATIONS | 235716 | CHECK/WIRE |
| SOUTH AMERICA | MATERNAL & CHILD HEALTH | 62403 | CHECK/WIRE |
| SOUTH AMERICA | REPRODUCTIVE HEALTH | 114705 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 11865 | CHECK/WIRE |
| SOUTH ASIA | MATERNAL & CHILD HEALTH | 63294 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 40000 | CHECK/WIRE |
| SOUTH ASIA | HEALTH TECHOLOGIES | 56882 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 64976 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 15000 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 10000 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | REPRODUCTIVE HEALTH | 10000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 6250 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 223243 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 20316 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | HEALTH TECHOLOGIES | 12075 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 18705 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 14449 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 14708 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 18222 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 17742 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10433 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 13851 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 19064 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 17004 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 11991 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10767 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 47864 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 83896 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 5349 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 25000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 16382 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 34358 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 929805 | CHECK/WIRE |
| EUROPE | HEALTH TECHOLOGIES | 50000 | CHECK/WIRE |
| EUROPE | HEALTH TECHOLOGIES | 86000 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 17177 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 14022 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 18674 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 14576 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | MATERNAL & CHILD HEALTH | 692440 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 556198 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 18141 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 13846 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 32344 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 16536 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 29217 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 13038 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 1196184 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | VACCINES AND IMMUNIZATIONS | 162497 | CHECK/WIRE |
| EUROPE | HEALTH TECHOLOGIES | 33013 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 32419 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 28967 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 14204 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 15026 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | REPRODUCTIVE HEALTH | 25345 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10667 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 19082 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 15931 | CHECK/WIRE |
| SOUTH ASIA | REPRODUCTIVE HEALTH | 11858 | CHECK/WIRE |
| SOUTH ASIA | REPRODUCTIVE HEALTH | 15000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | REPRODUCTIVE HEALTH | 15000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | REPRODUCTIVE HEALTH | 15000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | HEALTH TECHOLOGIES | 12047 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 19598 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 81636 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 130442 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 6912 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 613298 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 11795 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 23336 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 13508 | CHECK/WIRE |
| SOUTH ASIA | REPRODUCTIVE HEALTH | 28174 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | REPRODUCTIVE HEALTH | 18060 | CHECK/WIRE |
| SOUTH ASIA | MATERNAL & CHILD HEALTH | 10010 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 101815 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 29747 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | VACCINES AND IMMUNIZATIONS | 94020 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 10358 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 60916 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 33586 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 5411 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 9158 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 9158 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 43450 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 504534 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 75275 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 16380 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 8584 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 15837 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 135631 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10479 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 13209 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 130365 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 105621 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 7165 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | VACCINES AND IMMUNIZATIONS | 85449 | CHECK/WIRE |
| EUROPE | HEALTH TECHOLOGIES | 176355 | CHECK/WIRE |
| EUROPE | HEALTH TECHOLOGIES | 24395 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 157096 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | REPRODUCTIVE HEALTH | 50000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 17460 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 58621 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 229207 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | VACCINES AND IMMUNIZATIONS | 1301069 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | REPRODUCTIVE HEALTH | 8750 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 5100 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 128009 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10215 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 59691 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 1500000 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 2748007 | CHECK/WIRE |
| RUSSIA AND THE NEWLY INDEPENDENT STATES | EMERGING AND EPIDEMIC DISEASES | 1181981 | CHECK/WIRE |
| SOUTH ASIA | MATERNAL & CHILD HEALTH | 8345 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 365993 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 85730 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 16495 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 15113 | CHECK/WIRE |
| SOUTH ASIA | VACCINES AND IMMUNIZATIONS | 1800000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 87053 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 14930 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 8287 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 56850 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 14103 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 83699 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 13296 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 12852 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 20830 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 12901 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 11839 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 103036 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 5494 | CHECK/WIRE |
| MIDDLE EAST AND NORTH AFRICA | MATERNAL & CHILD HEALTH | 39999 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 19165 | CHECK/WIRE |
| RUSSIA AND THE NEWLY INDEPENDENT STATES | EMERGING AND EPIDEMIC DISEASES | 19810 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 5499 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | MATERNAL & CHILD HEALTH | 6599 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 13745 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | REPRODUCTIVE HEALTH | 15000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | REPRODUCTIVE HEALTH | 7513 | CHECK/WIRE |
| SOUTH AMERICA | HEALTH TECHOLOGIES | 23959 | CHECK/WIRE |
| SOUTH AMERICA | HEALTH TECHOLOGIES | 31046 | CHECK/WIRE |
| SOUTH AMERICA | HEALTH TECHOLOGIES | 38131 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 876517 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 55000 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 49674 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 508754 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | HEALTH TECHOLOGIES | 80419 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | HEALTH TECHOLOGIES | 19869 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 40000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | REPRODUCTIVE HEALTH | 43015 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 60000 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 722350 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 189517 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | VACCINES AND IMMUNIZATIONS | 399143 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 17212 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | HEALTH TECHOLOGIES | 50000 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 64088 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 27289 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | EMERGING AND EPIDEMIC DISEASES | 26661 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | VACCINES AND IMMUNIZATIONS | 11679 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | REPRODUCTIVE HEALTH | 5278 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 24349 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | VACCINES AND IMMUNIZATIONS | 589920 | CHECK/WIRE |
| CENTRAL AMERICA AND THE CARIBBEAN | REPRODUCTIVE HEALTH | 19545 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 19573 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 18506 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 24551 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 10868 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 25407 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 7674 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | HEALTH TECHOLOGIES | 18946 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | HEALTH TECHOLOGIES | 20000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | HEALTH TECHOLOGIES | 15000 | CHECK/WIRE |
| EAST ASIA AND THE PACIFIC | MATERNAL & CHILD HEALTH | 126298 | CHECK/WIRE |
| EUROPE | HEALTH TECHOLOGIES | 240116 | CHECK/WIRE |
| EUROPE | MATERNAL & CHILD HEALTH | 38138 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 55624 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 700172 | CHECK/WIRE |
| EUROPE | VACCINES AND IMMUNIZATIONS | 1673389 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 222584 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | EMERGING AND EPIDEMIC DISEASES | 47746 | CHECK/WIRE |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Number Of501c3 Orgs | 206 | TotalNumberOf501c3Orgs |
| Total Number Of Other Orgs | 42 | TotalNumberOfOtherOrgs |
| Transfer To Foreign Corp | 1 | TransferToForeignCorp |
| Interest In Foreign Trust | 0 | InterestInForeignTrust |
| Own Foreign Corp | 0 | OwnForeignCorp |
| Passive Foreign Invest Co | 0 | PassiveForeignInvestCo |
| Foreign Partnership | 0 | ForeignPartnership |
| Boycott Countries | 0 | BoycottCountries |
Form990 Schedule F Part V Form990ScheduleFPartV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: | Identifier |
| Explanation | SCHEDULE F, PART I, LINE 2: SUBRECIPIENTS MUST SUBMIT PROGRESS REPORTS THAT ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS OR FOLLOW UP ON ANY AREA OF CONCERN. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET FUTURE BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME. | Explanation |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | 1 | RecordsMaintained |
Recipient Table RecipientTable (102 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EIN Of RecipientEINOfRecipient | IRC SectionIRCSection | Amount Of Cash GrantAmountOfCashGrant | Purpose Of GrantPurposeOfGrant | Address Line2AddressUS/AddressLine2 |
|---|---|---|---|---|---|---|---|---|
| AKROS INC - RESEARCH ANALYTICS | ||||||||
| PO BOX 457 | LARAMIE | WY | 82073 | 263669995 | N/A | 667422 | EMERGING AND EPIDEMIC DISEASES | |
| BROADREACH HEALTHCARE LLC | ||||||||
| 2500 WILSON BLVD SUITE 220 | ARLINGTON | VA | 222013848 | 861052728 | N/A | 1433706 | EMERGING AND EPIDEMIC DISEASES | |
| ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION | ||||||||
| 1140 CONNECTICUT AVE NW | WASHINGTON | DC | 20036 | 954191698 | 501(C)(3) | 3906688 | EMERGING AND EPIDEMIC DISEASES | |
| ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION | ||||||||
| 1140 CONNECTICUT AVE NW | WASHINGTON | DC | 20036 | 954191698 | 501(C)(3) | 530167 | EMERGING AND EPIDEMIC DISEASES | |
| ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION | ||||||||
| 1140 CONNECTICUT AVE NW | WASHINGTON | DC | 20036 | 954191698 | 501(C)(3) | 121719 | EMERGING AND EPIDEMIC DISEASES | |
| EMORY UNIVERSITY | ||||||||
| 1599 CLIFTON RD NE 4TH FLOOR | ATLANTA | GA | 30322 | 580566256 | 501(C)(3) | 1489482 | EMERGING AND EPIDEMIC DISEASES | MAILSTOP 1499/001/1BH |
| EMPOWERING COMMUNICATIONS | ||||||||
| 13273 FIJI WAY 210 | MARINA DEL REY | CA | 90292 | 561843042 | N/A | 25313 | EMERGING AND EPIDEMIC DISEASES | |
| FAMILY HEALTH INTERNATIONAL (FHI) | ||||||||
| CHANCERY BLVD 2ND FLOOR | WASHINGTON | DC | 20036 | 237413005 | 501(C)(3) | 52685 | EMERGING AND EPIDEMIC DISEASES | |
| FAMILY HEALTH INTERNATIONAL (FHI) | ||||||||
| CHANCERY BLVD 2ND FLOOR | WASHINGTON | DC | 20036 | 237413005 | 501(C)(3) | 10000 | EMERGING AND EPIDEMIC DISEASES | |
| HEALTH ALLIANCE INTERNATIONAL | ||||||||
| 4534 11TH AVE NE | SEATTLE | WA | 98105 | 943047981 | 501(C)(3) | 357084 | EMERGING AND EPIDEMIC DISEASES | |
| JHPIEGO | ||||||||
| 1615 THAMES STREET | BALTIMORE | MD | 21231 | 237424444 | N/A | 4189462 | EMERGING AND EPIDEMIC DISEASES | |
| MEDICAL CARE DEVELOPMENT INC (MCD) | ||||||||
| 8401 COLESVILLE ROAD 425 | SILVER SPRING | MD | 20910 | 016022787 | 501(C)(3) | 38000 | EMERGING AND EPIDEMIC DISEASES | |
| PATHFINDER INTERNATIONAL | ||||||||
| NINE GALEN ST SUITE 217 | WATERTOWN | MA | 02472 | 530235320 | 501(C)(3) | 484092 | EMERGING AND EPIDEMIC DISEASES | |
| POPULATION ACTION INTERNATIONAL | ||||||||
| 1300 19TH ST NW | WASHINGTON | DC | 20036 | 520812075 | 501(C)(3) | 125000 | EMERGING AND EPIDEMIC DISEASES | |
| POPULATION COUNCIL | ||||||||
| CHANCERY BLVD 2ND FLOOR | NEW YORK | NY | 10017 | 520595110 | 501(C)(3) | 754193 | EMERGING AND EPIDEMIC DISEASES | |
| SOUTH AFRICA PARTNERS | ||||||||
| 89 SOUTH STREET SUITE 700 | BOSTON | MA | 021112679 | 043396641 | 501(C)(3) | 6764 | EMERGING AND EPIDEMIC DISEASES | |
| THE GLOBAL BUSINESS COALITION ON HIVAIDS TUBERCULOSIS AND MALARIA (GBC) | ||||||||
| 110 WILLIAM ST SUITE 1800 | NEW YORK | NY | 10038 | 134185520 | 501(C)(3) | 114015 | EMERGING AND EPIDEMIC DISEASES | |
| THE POPULATION COUNCIL | ||||||||
| CHANCERY BLVD 2ND FLOOR | NEW YORK | NY | 10017 | 912088484 | 501(C)(3) | 942594 | EMERGING AND EPIDEMIC DISEASES | |
| TULANE UNIVERSITY | ||||||||
| 1440 CANAL ST | NEW ORLEANS | LA | 70112 | 720423889 | 501(C)(3) | 331671 | EMERGING AND EPIDEMIC DISEASES | |
| WOMEN DELIVER | ||||||||
| 588 BROADWAY SUITE 5033 | NEW YORK | NY | 10012 | 264462256 | N/A | 600000 | EMERGING AND EPIDEMIC DISEASES | |
| WORLD VISION | ||||||||
| 300 I ST NE | WASHINGTON | DC | 20002 | 951922279 | 501(C)(3) | 3927245 | EMERGING AND EPIDEMIC DISEASES | |
| BERKELEY AIR MONITORING GROUP | ||||||||
| 46 SHATTUCK AVE | BERKELEY | CA | 94704 | 263881064 | N/A | 6360 | HEALTH TECHOLOGIES | |
| BETH ISRAEL DEACONESS MEDICAL CENTER | ||||||||
| 330 BROOKLINE AVE | BOSTON | MA | 02215 | 042103881 | 501(C)(3) | 18823 | HEALTH TECHOLOGIES | |
| CASCADE DESIGNS INC | ||||||||
| 4000 FIRST AVE S | SEATTLE | WA | 98134 | 910969695 | N/A | 6000 | HEALTH TECHOLOGIES | |
| CASCADE DESIGNS INC | ||||||||
| 4000 FIRST AVE S | SEATTLE | WA | 98134 | 910969695 | N/A | 130457 | HEALTH TECHOLOGIES | |
| CDC FOUNDATION | ||||||||
| 55 PARK PLACE SUITE 400 | ATLANTA | GA | 30303 | 582106707 | 501(C)(3) | 27920 | HEALTH TECHOLOGIES | |
| CONRAD | ||||||||
| 1911 N FORT MYER DR SUITE 900 | ARLINGTON | VA | 22209 | 546055378 | 501(C)(3) | 67030 | HEALTH TECHOLOGIES | |
| DIGITAL GREEN FOUNDATION | ||||||||
| 2342 SHATTUCK AVE 151 | BERKELEY | CA | 94704 | 262418959 | 501(C)(3) | 17391 | HEALTH TECHOLOGIES | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| PO BOX 19024 | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | 39763 | HEALTH TECHOLOGIES | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| PO BOX 19024 | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | 96207 | HEALTH TECHOLOGIES | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| PO BOX 19024 | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | 95993 | HEALTH TECHOLOGIES | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| PO BOX 19024 | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | 42835 | HEALTH TECHOLOGIES | |
| INSTITUTE FOR ONE WORLD HEALTH | ||||||||
| 280 UTAH AVE SUITE 250 | S SAN FRANCISCO | CA | 94080 | 943384500 | 501(C)(3) | 254145 | HEALTH TECHOLOGIES | |
| IQUUM INC | ||||||||
| 700 NICKERSON RD | MARLBOROUGH | MA | 01752 | 043471059 | N/A | 54057 | HEALTH TECHOLOGIES | |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 55 FRUIT STREET | BOSTON | MA | 02114 | 041564655 | 501(C)(3) | 10000 | HEALTH TECHOLOGIES | |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 55 FRUIT STREET | BOSTON | MA | 02114 | 041564655 | 501(C)(3) | 10000 | HEALTH TECHOLOGIES | |
| NORTHWESTERN UNIVERSITY | ||||||||
| 633 CLARK STREET | EVANSTON | IL | 60208 | 362167817 | 501(C)(3) | 26148 | HEALTH TECHOLOGIES | |
| PUBLIC HEALTH INSTITUTE | ||||||||
| 555 12TH STREET 10TH FLOOR | OAKLAND | CA | 946074046 | 941646278 | 501(C)(3) | 352519 | HEALTH TECHOLOGIES | |
| SYMBIENT PRODUCT DEVELOPMENT | ||||||||
| 1061 LA MIRADA COURT | VISTA | CA | 92081 | 200857602 | N/A | 68623 | HEALTH TECHOLOGIES | |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||
| 104 AIRPORT DRIVE CB 1350 | CHAPEL HILL | NC | 275991350 | 566001393 | 501(C)(3) | 38427 | HEALTH TECHOLOGIES | |
| UNIVERSITY OF PITTSBURGH | ||||||||
| 204 CRAFT AVE | PITTSBURGH | PA | 15213 | 250965591 | 501(C)(3) | 21055 | HEALTH TECHOLOGIES | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | 438461 | HEALTH TECHOLOGIES | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | 70653 | HEALTH TECHOLOGIES | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | 38834 | HEALTH TECHOLOGIES | |
| VILLAGEREACH | ||||||||
| 601 N 34TH STREET | SEATTLE | WA | 98103 | 912083484 | 501(C)(3) | 145000 | HEALTH TECHOLOGIES | |
| VILLAGEREACH | ||||||||
| 601 N 34TH STREET | SEATTLE | WA | 98103 | 912083484 | 501(C)(3) | 8985 | HEALTH TECHOLOGIES | |
| YALE UNIVERSITY | ||||||||
| 47 COLLEGE SUITE SUITE 216 | NEW HAVEN | CT | 065103209 | 060646973 | 501(C)(3) | 321030 | HEALTH TECHOLOGIES | |
| CARE INC | ||||||||
| 151 ELLIS ST NE | ATLANTA | GA | 300302440 | 131685039 | 501(C)(3) | 122760 | MATERNAL & CHILD HEALTH | |
| JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH | ||||||||
| 615 N WOLFE STREET W1100 | BALTIMORE | MD | 21205 | 520595110 | 501(C)(3) | 188030 | MATERNAL & CHILD HEALTH | |
| KANSAS STATE UNIVERSITY | ||||||||
| 2 FAIRCHILD HALL | MANHATTAN | KS | 665061103 | 480771751 | 501(C)(3) | 163404 | MATERNAL & CHILD HEALTH | |
| WORLD VISION INC | ||||||||
| PO BOX 9716 DEPT W | FEDERAL WAY | WA | 980639716 | 951922279 | 501(C)(3) | 157124 | MATERNAL & CHILD HEALTH | |
| FAMILY HEALTH INTERNATIONAL (FHI) | ||||||||
| CHANCERY BLVD 2ND FLOOR | WASHINGTON | DC | 20036 | 237413005 | 501(C)(3) | 377035 | REPRODUCTIVE HEALTH | |
| GEORGETOWN UNIVERSITY INSTITUTE FOR REPRODUCTIVE HEALTH | ||||||||
| 4301 CONNECTICUT AVE NW SUITE 310 | WASHINGTON | DC | 20008 | 500196603 | 501(C)(3) | 111998 | REPRODUCTIVE HEALTH | |
| INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF) | ||||||||
| 120 WALL ST 9TH FLOOR | NEW YORK | NY | 10005 | 131845455 | N/A | 56922 | REPRODUCTIVE HEALTH | |
| JHPIEGO | ||||||||
| 1615 THAMES STREET | BALTIMORE | MD | 21231 | 237424444 | N/A | 109666 | REPRODUCTIVE HEALTH | |
| JOHN SNOW INC | ||||||||
| 1616 N FORT MYER DR 16TH FLOOR | ARLINGTON | VA | 22209 | 042578580 | N/A | 18062 | REPRODUCTIVE HEALTH | |
| POPULATION ACTION INTERNATIONAL | ||||||||
| 1300 19TH ST NW | WASHINGTON | DC | 20036 | 520812075 | 501(C)(3) | 17500 | REPRODUCTIVE HEALTH | |
| POPULATION REFERENCE BUREAU (PRB) | ||||||||
| 1875 CONNECTICUT AVE NW | WASHINGTON | DC | 20009 | 530214030 | 501(C)(3) | 24020 | REPRODUCTIVE HEALTH | |
| POPULATION SERVICES INTERNATIONAL (PSI) | ||||||||
| 1120 19TH STREET NW SUITE 600 | WASHINGTON | DC | 20036 | 560942853 | 501(C)(3) | 15000 | REPRODUCTIVE HEALTH | |
| ALBERT B SABIN VACCINE INSTITUTE | ||||||||
| 2000 PENNSYLVANIA AVE SUITE 7100 | WASHINGTON | DC | 20006 | 061389829 | 501(C)(3) | 40000 | VACCINES AND IMMUNIZATIONS | |
| BIOJECT INC | ||||||||
| 20245 SW 95TH AVE | TUALATIN | OR | 97062 | 930881020 | N/A | 35000 | VACCINES AND IMMUNIZATIONS | |
| CDC FOUNDATION | ||||||||
| 55 PARK PLACE SUITE 400 | ATLANTA | GA | 30303 | 582106707 | 501(C)(3) | 22737 | VACCINES AND IMMUNIZATIONS | |
| EMORY UNIVERSITY | ||||||||
| 1599 CLIFTON RD NE 4TH FLOOR | ATLANTA | GA | 30322 | 580566256 | 501(C)(3) | 11524 | VACCINES AND IMMUNIZATIONS | MAILSTOP 1499/001/1BH |
| FOOD & DRUG ADMINISTRATION (FDA) | ||||||||
| 10903 NEW HAMPSHIRE AVE | SILVER SPRING | MD | 20093 | 530196965 | GOVERNMENT | 75000 | VACCINES AND IMMUNIZATIONS | |
| FOOD & DRUG ADMINISTRATION (FDA) | ||||||||
| 10903 NEW HAMPSHIRE AVE | SILVER SPRING | MD | 20093 | 530196965 | GOVERNMENT | 90592 | VACCINES AND IMMUNIZATIONS | |
| FOOD & DRUG ADMINISTRATION (FDA) | ||||||||
| 10903 NEW HAMPSHIRE AVE | SILVER SPRING | MD | 20093 | 530196965 | GOVERNMENT | 326675 | VACCINES AND IMMUNIZATIONS | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| PO BOX 19024 | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | 10205 | VACCINES AND IMMUNIZATIONS | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| PO BOX 19024 | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | 15308 | VACCINES AND IMMUNIZATIONS | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| PO BOX 19024 | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | 23986 | VACCINES AND IMMUNIZATIONS | |
| GEORGE WASHINGTON UNIVERSITY | ||||||||
| 2121 I STREET NW SUITE 601 | WASHINGTON | DC | 20052 | 530196584 | N/A | 64350 | VACCINES AND IMMUNIZATIONS | |
| INOVIO BIOMEDICAL CORPORATION | ||||||||
| 450 SENTRY PARKWAY | BLUE BELL | PA | 19422 | 330969592 | N/A | 497116 | VACCINES AND IMMUNIZATIONS | |
| JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH | ||||||||
| 615 N WOLFE STREET W1100 | BALTIMORE | MD | 21205 | 520595110 | 501(C)(3) | 104325 | VACCINES AND IMMUNIZATIONS | |
| JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH | ||||||||
| 615 N WOLFE STREET W1100 | BALTIMORE | MD | 21205 | 520595110 | 501(C)(3) | 42146 | VACCINES AND IMMUNIZATIONS | |
| JOHNS HOPKINS UNIVERSITY | ||||||||
| 615 N WOLFE STREET | BALTIMORE | MD | 21205 | 131687001 | 501(C)(3) | 17769 | VACCINES AND IMMUNIZATIONS | |
| NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) | ||||||||
| 6610 ROCKLEDGE DR SUITE 2800 | BETHESDA | MD | 208926606 | 520858115 | GOVERNMENT | 953690 | VACCINES AND IMMUNIZATIONS | |
| NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) | ||||||||
| 6610 ROCKLEDGE DR SUITE 2800 | BETHESDA | MD | 208926606 | 520858115 | GOVERNMENT | 361228 | VACCINES AND IMMUNIZATIONS | |
| NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) | ||||||||
| 6610 ROCKLEDGE DR SUITE 2800 | BETHESDA | MD | 208926606 | 520858115 | GOVERNMENT | 109581 | VACCINES AND IMMUNIZATIONS | |
| NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) | ||||||||
| 6610 ROCKLEDGE DR SUITE 2800 | BETHESDA | MD | 208926606 | 520858115 | GOVERNMENT | 205770 | VACCINES AND IMMUNIZATIONS | |
| NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) | ||||||||
| 6610 ROCKLEDGE DR SUITE 2800 | BETHESDA | MD | 208926606 | 520858115 | GOVERNMENT | 50754 | VACCINES AND IMMUNIZATIONS | |
| NAVAL MEDICAL RESEARCH CENTER (NMRC) | ||||||||
| 503 ROBERT GRANT AVE | SILVER SPRING | MD | 209107500 | 470100048 | GOVERNMENT | 79627 | VACCINES AND IMMUNIZATIONS | |
| NEW YORK UNIVERSITY | ||||||||
| 650 FIRST AVE | NEW YORK | NY | 10016 | 135562308 | 501(C)(3) | 59149 | VACCINES AND IMMUNIZATIONS | |
| PAN AMERICAN HEALTH ORGANIZATION (PAHO) | ||||||||
| 525 23RD STREET NW | WASHINGTON | DC | 20037 | 237072046 | 501(C)(3) | 75000 | VACCINES AND IMMUNIZATIONS | |
| PARALLEL SOLUTIONS INC | ||||||||
| 767 C CONCORD AVENUE | CAMBRIDGE | MA | 02138 | 043565762 | N/A | 15000 | VACCINES AND IMMUNIZATIONS | |
| PARALLEL SOLUTIONS INC | ||||||||
| 767 C CONCORD AVENUE | CAMBRIDGE | MA | 02138 | 043565762 | N/A | 30000 | VACCINES AND IMMUNIZATIONS | |
| PROFECTUS BIOSCIENCES INC | ||||||||
| 6411 BECKLEY STREET | BALTIMORE | MD | 21224 | 020579416 | N/A | 191305 | VACCINES AND IMMUNIZATIONS | |
| SABIN VACCINE INSTITUTE | ||||||||
| 2000 PENNSYLVANIA AVE SUITE 7100 | WASHINGTON | DC | 20006 | 061389829 | 501(C)(3) | 10000 | VACCINES AND IMMUNIZATIONS | |
| SANARIA INC | ||||||||
| 9800 MEDICAL CENTER DR SUITE A | ROCKVILLE | MD | 20850 | 562354362 | N/A | 120000 | VACCINES AND IMMUNIZATIONS | |
| SEATTLE BIOMEDICAL RESEARCH INSTITUTE | ||||||||
| 1660 S COLUMBIAN WAY S-151F | SEATTLE | WA | 98108 | 910961784 | 501(C)(3) | 44123 | VACCINES AND IMMUNIZATIONS | |
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC | ||||||||
| 2385 IRVING HILL ROAD | LAWRENCE | KS | 66045 | 480680117 | 501(C)(3) | 82500 | VACCINES AND IMMUNIZATIONS | |
| UNIVERSITY OF MARYLAND BALTIMORE | ||||||||
| 620 W LEXINGTON ST | BALTIMORE | MD | 21201 | 526002033 | 501(C)(3) | 23364 | VACCINES AND IMMUNIZATIONS | |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL THE | ||||||||
| 104 AIRPORT DRIVE CB 1350 | CHAPEL HILL | NC | 275991350 | 566001393 | 501(C)(3) | 8894 | VACCINES AND IMMUNIZATIONS | |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL THE | ||||||||
| 104 AIRPORT DRIVE CB 1350 | CHAPEL HILL | NC | 275991350 | 566001393 | 501(C)(3) | 35574 | VACCINES AND IMMUNIZATIONS | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | 48053 | VACCINES AND IMMUNIZATIONS | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | 5996 | VACCINES AND IMMUNIZATIONS | |
| WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) | ||||||||
| 503 ROBERT GRANT AVE | SILVER SPRING | MD | 109107500 | 520664528 | GOVERNMENT | 185141 | VACCINES AND IMMUNIZATIONS | |
| WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) | ||||||||
| 503 ROBERT GRANT AVE | SILVER SPRING | MD | 109107500 | 520664528 | GOVERNMENT | 149865 | VACCINES AND IMMUNIZATIONS | |
| WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) | ||||||||
| 503 ROBERT GRANT AVE | SILVER SPRING | MD | 109107500 | 520664528 | GOVERNMENT | 251872 | VACCINES AND IMMUNIZATIONS | |
| PATH DRUG SOLUTIONS | ||||||||
| 2201 WESTLAKE AVE SUITE 200 | SEATTLE | WA | 98121 | 943384500 | 501(C)(3) | 1231793 | EMERGING AND EPIDEMIC DISEASES | |
| WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) | ||||||||
| 503 ROBERT GRANT AVE | SILVER SPRING | MD | 109107500 | 520664528 | GOVERNMENT | 40314 | VACCINES AND IMMUNIZATIONS | |
| (no name) | ||||||||
| REPRODUCTIVE HEALTH REPRODUCTIVE HEALTH | ||||||||
| MANOFF GROUP | ||||||||
| 4301 CONNECTICUT AVE NW SUITE 310 | WASHINGTON | DC | 20006 | 043030192 | N/A | -9241 | MATERNAL & CHILD HEALTH | |
| SABIN VACCINE INSTITUTE | ||||||||
| 2000 PENNSYLVANIA AVE SUITE 7100 | WASHINGTON | DC | 20006 | 061389829 | 501(C)(3) | -19436 | VACCINES AND IMMUNIZATIONS | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Nbr Of501 C3 And Govt Grants | 42 | TotalNbrOf501C3AndGovtGrants |
| Total Nbr Of Other Organizations | 20 | TotalNbrOfOtherOrganizations |
Form990 Schedule I Part IV Form990ScheduleIPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | PROCEDURE FOR MONITORING GRANTS IN THE U.S.: | Identifier |
| Return Reference | PART I, LINE 2: | ReturnReference |
| Explanation | SCHEDULE I, PART I, LINE 2: SUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET FUTURE BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME. | Explanation |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Idemnification Gross Up Payments | X | IdemnificationGrossUpPayments |
| Housing Allowance Or Residence | X | HousingAllowanceOrResidence |
| Written Policy Re T And E Expenses | 1 | WrittenPolicyReTAndEExpenses |
| Substantiation Required | 1 | SubstantiationRequired |
| Compensation Committee | X | CompensationCommittee |
| Independent Consultant | X | IndependentConsultant |
| Compensation Survey | X | CompensationSurvey |
| Board Or Committee Approval | X | BoardOrCommitteeApproval |
| Severance Payment | 0 | SeverancePayment |
| Supplemental Nonqual Retire Plan | 0 | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | 0 | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | 0 | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | 0 | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | 0 | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | 0 | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | 1 | AnyNonFixedPayments |
| Initial Contract Exception | 0 | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII (28 entries)
| TitleTitle | Base Compensation Filing OrgBaseCompensationFilingOrg | Comp Based On Related OrgsCompBasedOnRelatedOrgs | Bonus Filing OrgBonusFilingOrg | Bonus Related OrgsBonusRelatedOrgs | Other Compensation Filing OrgOtherCompensationFilingOrg | Other Compensation Related OrgsOtherCompensationRelatedOrgs | Deferred Comp Filing OrgDeferredCompFilingOrg | Deferred Comp Related OrgsDeferredCompRelatedOrgs | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg | Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs | Total Compensation Filing OrgTotalCompensationFilingOrg | Total Compensation Related OrgsTotalCompensationRelatedOrgs | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg | Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHRISTOPHER J ELIAS | ||||||||||||||
| PRESIDENT AND CEO (UNTIL 1/31/12) | 100133 | 0 | 123321 | 0 | 50 | 0 | 12016 | 0 | 889 | 0 | 236409 | 0 | 0 | 0 |
| STEVEN B DAVIS | ||||||||||||||
| PRESIDENT AND CEO (BEGAN 6/1/12) | 205500 | 0 | 10000 | 0 | 100 | 0 | 12241 | 0 | 7112 | 0 | 234953 | 0 | 0 | 0 |
| ERIC G WALKER | ||||||||||||||
| VP, CORPORATE SERVICES | 240882 | 0 | 10000 | 0 | 1140 | 0 | 26368 | 0 | 10635 | 0 | 289025 | 0 | 0 | 0 |
| AYORINDE ARNOLD AJAYI | ||||||||||||||
| VP, INTERNATIONAL DEVELOPMENT | 250390 | 0 | 10000 | 0 | 0 | 0 | 29540 | 0 | 6256 | 0 | 296186 | 0 | 0 | 0 |
| CARLOS CLINTON CAMPBELL | ||||||||||||||
| DIR., MALARIA CONTROL PROGRAM | 186683 | 0 | 0 | 0 | 12555 | 0 | 19266 | 0 | 2531 | 0 | 221035 | 0 | 0 | 0 |
| CATHARINE HOWARD TAYLOR | ||||||||||||||
| GLOBAL PROGRAM LEADER, MCHN | 204790 | 0 | 0 | 0 | 0 | 0 | 24491 | 0 | 7689 | 0 | 236970 | 0 | 0 | 0 |
| DANIEL LASTER | ||||||||||||||
| GENERAL COUNSEL | 205697 | 0 | 10000 | 0 | 28 | 0 | 23873 | 0 | 10584 | 0 | 250182 | 0 | 0 | 0 |
| DAVID C KASLOW | ||||||||||||||
| MVI PROGRAM LEADER | 232506 | 0 | 20000 | 0 | 15100 | 0 | 18600 | 0 | 8359 | 0 | 294565 | 0 | 0 | 0 |
| ERIC A ARNOLD | ||||||||||||||
| CHIEF INFORMATION OFFICER | 201774 | 0 | 0 | 0 | 125 | 0 | 24112 | 0 | 10524 | 0 | 236535 | 0 | 0 | 0 |
| JACQUELINE D SHERRIS | ||||||||||||||
| VP, PUBLIC HEALTH IMPACT | 250390 | 0 | 10000 | 0 | 300 | 0 | 27617 | 0 | 2876 | 0 | 291183 | 0 | 0 | 0 |
| JANE E HUTCHINGS | ||||||||||||||
| DIRECTOR, REPRODUCTIVE HEALTH | 188006 | 0 | 0 | 0 | 0 | 0 | 21905 | 0 | 10521 | 0 | 220432 | 0 | 0 | 0 |
| JOAN LITTLEFIELD | ||||||||||||||
| COUNTRY PROGRAM LEADER, ZAMBIA | 129918 | 0 | 0 | 0 | 71858 | 0 | 14239 | 0 | 8405 | 0 | 224420 | 0 | 0 | 0 |
| JOHN W BOSLEGO | ||||||||||||||
| DIR, VACCINE DEV. GLOBAL PROGRAM | 315915 | 0 | 15000 | 0 | 0 | 0 | 30000 | 0 | 8973 | 0 | 369888 | 0 | 0 | 0 |
| JULIE M PULERWITZ | ||||||||||||||
| DIR, HIV/AIDS & TB GLOBAL PROG. | 177897 | 0 | 0 | 0 | 0 | 0 | 21260 | 0 | 8749 | 0 | 207906 | 0 | 0 | 0 |
| KATHLEEN M NEUZIL | ||||||||||||||
| GLOBAL PROGRAM LEADER, VAD | 221351 | 0 | 0 | 0 | 225 | 0 | 23511 | 0 | 9958 | 0 | 255045 | 0 | 0 | 0 |
| KATHRYN A O'DRISCOLL | ||||||||||||||
| CHIEF HUMAN RESOURCES OFFICER | 196634 | 0 | 0 | 0 | 940 | 0 | 19122 | 0 | 10521 | 0 | 227217 | 0 | 0 | 0 |
| MARLOW KEE | ||||||||||||||
| CHIEF FINANCIAL OFFICER | 200324 | 0 | 0 | 0 | 3247 | 0 | 23370 | 0 | 10522 | 0 | 237463 | 0 | 0 | 0 |
| MICHAEL J FREE | ||||||||||||||
| VP & SR. ADVISOR FOR TECHNOLOGIES | 217699 | 0 | 0 | 0 | 0 | 0 | 26124 | 0 | 10327 | 0 | 254150 | 0 | 0 | 0 |
| MICHELLE FOLSOM | ||||||||||||||
| DIRECTOR, PROGRAM DEVELOPMENT | 171441 | 0 | 0 | 0 | 0 | 0 | 20573 | 0 | 7531 | 0 | 199545 | 0 | 0 | 0 |
| RACHEL WILSON | ||||||||||||||
| SENIOR DIRECTOR, POLICY & ADVOCACY | 175471 | 0 | 0 | 0 | 990 | 0 | 21082 | 0 | 9345 | 0 | 206888 | 0 | 0 | 0 |
| RAMONA ANNE BYRKIT | ||||||||||||||
| COUNTRY PROG. LEADER, VIETMAN | 144426 | 0 | 0 | 0 | 75297 | 0 | 16552 | 0 | 8482 | 0 | 244757 | 0 | 0 | 0 |
| RIKKA E TRANGSRUD | ||||||||||||||
| COUNTRY PROGRAM LEADER, KENYA | 163768 | 0 | 0 | 0 | 62899 | 0 | 18557 | 0 | 9000 | 0 | 254224 | 0 | 0 | 0 |
| SARAH C TEMPLE | ||||||||||||||
| VP, EXTERNAL RELATIONS | 200255 | 0 | 10000 | 0 | 840 | 0 | 16271 | 0 | 7730 | 0 | 235096 | 0 | 0 | 0 |
| ASHLEY BIRKETT | ||||||||||||||
| DIRECTOR, RESEARCH & DEVELOPMENT | 232607 | 0 | 0 | 0 | 159 | 0 | 25582 | 0 | 10602 | 0 | 268950 | 0 | 0 | 0 |
| DUNCAN OWENS EARLE | ||||||||||||||
| PROG. DIR., MALARIA CONTROL & EVAL. | 204802 | 0 | 0 | 0 | 52527 | 0 | 24576 | 0 | 8813 | 0 | 290718 | 0 | 0 | 0 |
| JEAN A NTUMBA BIDUAYA | ||||||||||||||
| FINANCE & ADMIN. SPEC., HIV & TB | 79127 | 0 | 0 | 0 | 160262 | 0 | 8309 | 0 | 9830 | 0 | 257528 | 0 | 0 | 0 |
| JOHN SKIBIAK | ||||||||||||||
| DIRECTOR, RHSC | 176877 | 0 | 0 | 0 | 167627 | 0 | 21177 | 0 | 10499 | 0 | 376180 | 0 | 0 | 0 |
| TRAD M HATTON | ||||||||||||||
| CHIEF OF PARTY, INTEGRATED HIV/AIDS | 106648 | 0 | 0 | 0 | 124955 | 0 | 12798 | 0 | 10005 | 0 | 254406 | 0 | 0 | 0 |
Form990 Schedule J Part III Form990ScheduleJPartIII (2 entries)
| Return ReferenceReturnReference | ExplanationExplanation |
|---|---|
| PART I, LINE 1A | HOUSING ALLOWANCE & TAX INDEMNIFICATION ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITION. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT. |
| PART I, LINE 7 | BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II). |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTraded
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Number Of Contributions | 15 | NumberOfContributions |
| Noncash Contribs Rptd F990 | 197302 | NoncashContribsRptdF990 |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenues |
Other Non Cash Contributions Table OtherNonCashContributionsTable
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Description | SUPPLIES | Description |
| Number Of Contributions | 1 | NumberOfContributions |
| Noncash Contribs Rptd F990 | 135 | NoncashContribsRptdF990 |
| Method Of Determining Revenues | COST OR SALES PRICE | MethodOfDeterminingRevenues |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Number Of8283 Received | 0 | NumberOf8283Received |
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeld |
| Review Process Unusual NC Gifts | 1 | ReviewProcessUnusualNCGifts |
| Third Parties Used | 0 | ThirdPartiesUsed |
Form990 Schedule M Part II Form990ScheduleMPartII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | METHOD FOR DETERMINING NUMBER OF CONTRIBUTORS: | Identifier |
| Return Reference | PART I, COLUMN (B): | ReturnReference |
| Explanation | THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS. | Explanation |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (4 entries)
| Return ReferenceReturnReference | ExplanationExplanation |
|---|---|
| FORM 990, PART VI, SECTION B, LINE 11 | THE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE PRESIDENT AND CEO SIGNED THE RETURN AND FILED WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | BOARD MEMBERS, PATH MANAGEMENT, AND ALL STAFF ABOVE A DESIGNATED LEVEL IN THE ORGANIZATION MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY PERSON WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE BOARD'S COMPENSATION COMMITTEE ANNUALLY REVIEWS SALARY AND BENEFITS FOR KEY EMPLOYEE POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT AND CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR AT THE MAY BOARD MEETING. PATH ROUTINELY USES THE SERVICES OF EXTERNAL FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO AND VICE PRESIDENTS). THE LAST MAJOR REVIEW WAS COMPLETED IN 2011, WHEN PATH ENGAGED MERCER (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO, VICE PRESIDENTS, AND PROGRAM/DEPARTMENT LEADERS. MERCER USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD'S COMPENSATION COMMITTEE REVIEWED THE MERCER REPORT AND APPROVED THE COMPENSATION PACKAGES FOR THE VICE PRESIDENTS, WITH RATIFICATION BY THE BOARD. THE BOARD ALSO APPROVED THE COMMITTEE'S RECOMMENDATION FOR THE PRESIDENT/CEO'S COMPENSATION. ADDITIONALLY, MERCER REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFIT PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD REVIEWED MERCER'S FINDINGS AND APPROVED THE TOTAL PACKAGE FOR THIS POSITION. |
| FORM 990, PART VI, SECTION C, LINE 19 | PATH MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. |
Schedule R IRS990ScheduleR
Form990 Schedule R Part II Form990ScheduleRPartII (4 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EINEIN | Primary ActivitiesPrimaryActivities | Legal Domicile StateLegalDomicileState | Exempt Code SectionExemptCodeSection | Public Charity StatusPublicCharityStatus | Business Name Line1DirectControllingEntityName/BusinessNameLine1 | Controlled OrgControlledOrg | Address Line1AddressForeign/AddressLine1 | CityAddressForeign/City | CountryAddressForeign/Country | Legal Domicile Foreign CountryLegalDomicileForeignCountry | Province Or StateAddressForeign/ProvinceOrState |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PATH VACCINE SOLUTIONS | |||||||||||||||
| 2201 WESTLAKE AVENUE | SEATTLE | WA | 98109 | 830431851 | ADVANCE DEVELOPMENT OF VACCINES TO IMPROVE THE HEALTH OF CHILDREN | WA | 501(C)(3) | 11A | PATH | 1 | |||||
| ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH | |||||||||||||||
| REDUCE THE HEALTH BURDEN IN UKRAINE | N/A | N/A | PATH | 1 | 25 BUILDING B0 SHOTA RUSTAVELI STR | KYIV | UP | UP | |||||||
| PATH DRUG SOLUTIONS (FORMERLY INSTITUTE FOR ONEWORLD HEALTH) | |||||||||||||||
| 280 UTAH AVENUE SUITE 250 | SAN FRANCISCO | CA | 94080 | 943384500 | DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINES | CA | 501(C)(3) | 11A | PATH | 1 | |||||
| FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND | |||||||||||||||
| EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH | N/A | N/A | PATH | 1 | 207 ROUTE DE FERNEY 1218 LE GRAND-S | SZ | SZ | GENEVA | |||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Ann Rents Royalties | 0 | ReceiptOfIntAnnRentsRoyalties |
| Gift Grant Or Cap Contr To Other Org | 1 | GiftGrantOrCapContrToOtherOrg |
| Gift Grant Or Cap Contr Fr Other Org | 1 | GiftGrantOrCapContrFrOtherOrg |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrg |
| Loans Or Guarantees From Other Org | 0 | LoansOrGuaranteesFromOtherOrg |
| Dividends Related Organization | 0 | DividendsRelatedOrganization |
| Sale Of Assets To Other Org | 0 | SaleOfAssetsToOtherOrg |
| Purchase Of Assets From Other Org | 0 | PurchaseOfAssetsFromOtherOrg |
| Exchange Of Assets | 0 | ExchangeOfAssets |
| Rental Of Facilities To Other Orgs | 0 | RentalOfFacilitiesToOtherOrgs |
| Rental Of Facilities Fr Other Orgs | 0 | RentalOfFacilitiesFrOtherOrgs |
| Perform Of Services For Other Orgs | 0 | PerformOfServicesForOtherOrgs |
| Perform Of Services By Other Orgs | 0 | PerformOfServicesByOtherOrgs |
| Sharing Of Facilities | 0 | SharingOfFacilities |
| Sharing Of Paid Employees | 0 | SharingOfPaidEmployees |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrg |
| Reimbursement Paid By Other Org | 1 | ReimbursementPaidByOtherOrg |
| Other Transfer To Other Org | 0 | OtherTransferToOtherOrg |
| Other Transfer From Other Org | 0 | OtherTransferFromOtherOrg |
Transactions Related Orgs Table TransactionsRelatedOrgsTable (11 entries)
| Transaction TypeTransactionType | Amount InvolvedAmountInvolved | Method Of Amt DeterminationMethodOfAmtDetermination |
|---|---|---|
| PATH VACCINE SOLUTIONS | ||
| C | 12756027 | FMV |
| PATH VACCINE SOLUTIONS | ||
| Q | 27450457 | FMV |
| PATH VACCINE SOLUTIONS | ||
| B | 82082 | FMV |
| ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH | ||
| B | 1181981 | FMV |
| ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH | ||
| C | 117142 | FMV |
| ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH | ||
| Q | 2735923 | FMV |
| PATH DRUG SOLUTIONS | ||
| B | 1231793 | FMV |
| PATH DRUG SOLUTIONS | ||
| C | 1360058 | FMV |
| PATH DRUG SOLUTIONS | ||
| Q | 10347194 | FMV |
| FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND | ||
| B | 2748007 | FMV |
| FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND | ||
| Q | 2752089 | FMV |